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Human aging is the greatest risk factor for disease and mortality, however the 
molecular mechanisms are poorly understood. The process involves altered cellular 
function but occurs without predictable genetic change and is variable among individuals, 
indicating that epigenetic change may be involved.  DNA methylation is an epigenetic 
mark with important roles in regulating gene expression and cellular identity. Widespread 
differences in DNA methylation have been observed in cancer, EBV transformation of 
lymphocytes and replicative senescence. Early work considering epigenetic change in 
aging identified global changes in methylation highly variable among individuals.  
Recent work has identified specific genomic regions in which DNA methylation 
consistently changes with age, however the genome scale patterns and the factors 
underlying this change remain unclear.  
In this work, we use genome wide methods to clarify the nature of age related 
epigenetic change. Using human skin samples, we identify widespread genomic blocks of 
hypomethylation in chronically sun-exposed epidermis but not sun-protected, aged tissue, 
implicating environmental stress in mediating large-scale epigenetic change. The degree 
of hypomethylation in the identified blocks correlates with clinical measures of photo- 
aging and the identified blocks are further hypomethylated in squamous cell carcinoma 
samples compared to matched controls.   
In another study, using purified monocytes and lymphocytes from human 
peripheral blood, we observe highly cell type specific patterns of methylation change 
with age.  In lymphocytes, we observe widespread blocks of hypomethylation similar to 
 iii 
the changes identified in cancer and chronically sun-exposed epidermis, while in 
monocytes, no large-scale change is present with age.  In addition, we identify smaller 
regions differentially methylated with age in each cell type that occur in cell type specific 
enhancers and contain motifs for regulatory factor binding, indicating methylation change 
with age may be linked to the regulation of cell identity.   
Given the widespread blocks of hypomethylation observed in skin and blood 
systems, we investigate the link between block methylation and proliferation by using 
whole genome bisulfite sequencing to measure DNA methylation in growth arrested and 
actively dividing primary fibroblasts. We demonstrate that methylation in block regions 
is stable over replication and through extended arrest. 
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Epigenetics is the study of heritable regulation of the transcriptional program that 
is independent of the DNA sequence itself.  Conrad Waddington introduced the concept 
in the context of developmental biology. He noted that in a multicellular organism, a 
single cell develops into many cell types with distinct functions and identities, despite 
sharing an identical genotype. He proposed another level of information, the 
“epigenotype” as the mediator of this relationship between genotype and phenotype [1]. 
Today, epigenetic regulation is studied on multiple levels: DNA modifications to the 
DNA itself, modifications to the histone proteins around which DNA is wrapped, inter- 
and intra-chromosomal interactions, and localization of regions of DNA within the 
nucleus.   
DNA methylation is the most commonly studied epigenetic modification. DNA 
methylation refers to the addition of a methyl group to the 5’ position of the cytosine base. 
In mammals, it is most commonly found in the context of CpG dinucleotides, although 
cytosine methylation in other contexts has recently been reported in brain tissue and 
embryonic stem cells [2, 3].  CpGs are relatively depleted across vertebrate genomes, but 
are enriched in regions termed “CpG Islands”, which have a >50% CG content, average 
1000 bp and are most commonly found in gene promoters [4, 5]. While CpGs across the 
genome are generally heavily methylated, CpGs within islands have low levels of 
methylation, leading to a bimodal distribution pattern of methylation levels.  
The methylation mark is placed on DNA by methyltransferase enzymes that 
catalyze transfer of the methyl group from S-adenosyl methionine. In humans, three 
methyltransferase enzymes have been identified. DNMT1 functions as the maintenance 
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methyltransferase; it catalyzes methylation of hemimethylated DNA to maintain the 
existing pattern of methylation during cell division. This enzyme localizes to newly 
synthesized DNA through association with the replication complex during DNA 
replication; it also associates with other transcription factors outside of replication [6, 7]. 
The de novo methyltransferases, DNMT3a and DNMT3b, function in de novo 
methylation. These enzymes have both overlapping and distinct roles: both enzymes 
function in methylation of repeat elements and in CpG island methylation, while 
DNMT3b is specifically implicated in methylation at pericentromeric repeats and in 
intergenic methylation [8-10]. 
Methylation at a given location can be lost through multiple pathways.  Active 
demethylation occurs during development through hydroxylation by the Tet enzymes 
[11]. In addition, there is evidence of demethylation via deamination by AID followed by 
basis excision repair [12]. DNA methylation can be lost passively during DNA-
replication if DNMT1 fails to properly localize [13]. In development, this passive loss 
may be partially dependent on initial active demethylation by Tet [14, 15]. 
The presence of DNA methylation at CpG islands in gene promoters is linked to 
decreased expression of nearest genes. The presence of methylation can directly inhibit 
binding of some transcription factors [16, 17]. DNA methylation can also act through 
recruitment of the methyl dependent binding protein MeCP2, which recruits chromatin 
modifiers to repress transcription by condensing chromatin [18, 19]. By contrast, 
methylation of intergenic CpG islands is associated with active transcription [20]. 
Methylation found outside of genes is thought to function both in repression of 
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transcription of repeat sequences at centromeres, telomeres and repetitive elements and in 
control of recombination [21-24]. 
In recent years, rapidly developing array and sequencing technology has 
facilitated characterization of genome-wide methylation in a large variety of samples, and 
has thus provided insight into where methylation differs between cells and how 
methylation changes with disease. While previous methods were restricted to measuring 
methylation at CpG islands or repeat elements, the development of the comprehensive 
high-throughput arrays for relative methylation (CHARM, detailed below), technology in 
2009 allowed an unbiased comparison of genome-wide methylation between multiple 
tissue types. Using this method, Irizarry et al. observed that the regions differentially 
methylated between tissues are most frequently found not in CpG islands, but in the 
regions neighboring islands, termed “CpG shores” [25].  The differentially methylated 
shores identified in this work showed a strong inverse relationship between methylation 
and gene expression, indicating that these shore regions are an important location for 
regulation of gene expression.  Strikingly, comparing colon cancer and normal samples 
on the same array revealed cancer related differential methylation occurs in similar 
locations to those that differentiate tissues[25]. Further, comparing induced pluripotent 
stem cells and embryonic stem cells to fibroblasts revealed differentially methylated 
regions in the same CpG shores, suggesting that methylation at CpG shores plays a role 
in determining cellular identity and function [26]. 
The development of whole genome bisulfite sequencing (WGBS, detailed below) 
technology has allowed genome scale observations of where differential methylation 
occurs.  Through WGBS, large scale patterns of change have been observed in addition to 
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the small differentially methylated regions identified with array technology.  Sequencing 
of cultured fibroblasts revealed that in addition to the expected distribution of highly 
methylated and primarily unmethylated regions, large domains with intermediate levels 
(~70%) of methylation are present, termed partially methylated domains (PMDs) [27]. 
When colon cancer and normal colon samples were compared, widespread 
hypomethylation was observed in colon cancer, however this change was not uniform 
across the genome. The majority of hypomethylation in colon cancer samples was found 
to occur in large regions with low CpG and low gene density, called hypomethylated 
blocks [28]. These domains were observed to overlap strongly with the PMDs from 
fibroblasts. Further, they overlap with domains previously identified to associate with the 
nuclear membrane (LADs) and regions of condensed chromatin (LOCKs), both of which 
are associated with decreased transcription and have been implicated in regulation of 
cellular identity [29, 30]. A later study identified similar hypomethylated blocks 
associated with EBV transformation of lymphocytes, indicating that loss of methylation 
in blocks may occur early in the process of oncogenesis [31]. 
 In addition to its roles in embryonic development and cancer, maintenance of the 
methylome is essential for maintaining regenerative potential in adult progenitor cell 
populations and de novo methylation plays an important role in differentiation.  A 
comprehensive mapping of whole genome methylation in hematopoietic stem, progenitor 
and daughter cell populations demonstrated a highly specific process of de-methylation 
and re-methylation during differentiation [32]. The use of conditional knockouts has 
demonstrated that loss of DNMT1 leads to loss of regenerative capacity in hematopoietic 
and keratinocyte stem cells  and to loss of differentiation capacity in intestinal crypt stem 
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cells [33-35]. The de novo methyltransferases are implicated in mediating differentiation 
of regenerating cells: loss of DNMT3a and 3b in hematopoietic stem cells impairs 
differentiation [36], and DNMT3a is essential for osteoclast differentiation from 
precursor cells [37]. 
The mechanism of region-specific differential methylation is not understood. One 
study indicates binding of transcription factors at regulatory regions leads to local 
hypomethylation, suggesting a cell’s methylome may reflect which regulatory factors 
have recently been DNA bound [38]. Other work indicates that the de novo 
methyltransferases are recruited in complex with enzymes that promote heterochromatin 
formation [39, 40].  Given the strong overlap between hypomethylated blocks, lamina-
associated domains and heterochromatin domains, it is possible that altered methylation 
in these regions is a result of large scale nuclear reorganization. 
Methods to study genome-wide methylation 
 
The CHARM array, developed in 2009, offered one of the first opportunities to 
look at methylation genome-wide in an unbiased manner.  In this method, genomic DNA 
is sheared and half of the DNA is digested with McrBC, a restriction enzyme that cuts 
only when bound to methylated DNA.  After size selection, the digested and undigested 
DNA is then  purified, amplified and hybridized to a tiling array, covering the genome 
without bias towards CpG islands. The relative methylation at a given region is 
determined by comparing hybridization signal for each region from the MCRBC digested 
DNA to the undigested DNA: a weaker signal indicates more digestion and thus more 
methylation [41]. 
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The Illumina HumanMethylation27 beadchip (27k) and HumanMethylation450 
beadchip (450k) allow quantitative measurement of methylation at specific CpGs by 
applying genotyping technology to DNA treated with sodium bisulfite. The bisulfite 
treatment deaminates unmethylated cytosines to uracil. When this DNA is PCR amplified, 
methylated cytosines are amplified as cytosine, while converted, unmethylated, cytosines 
are amplified as thymidine. The Illumina arrays then measure the percentage of cytosines 
compared to thymidines at specific CpGs using preferential hybridization and extension 
[42]. The original 27k array measured only cytosines within CpG Islands, limiting its 
application for genome wide studies. The 450k array was developed after the CHARM 
array and was designed to assay CpGs within CpG islands, shores, and other regions 
shown to variably methylated across tissues, cell types and populations [43]. 
The development of whole genome bisulfite sequencing (WGBS) technology has 
allowed genome scale observations of where differential methylation occurs.  In this 
method bisulfite converted, PCR amplified DNA is sequenced. This allows quantitation 
of methylation at every cytosine across the genome by comparing the number of cytosine 
and thymidine reads at each location [44]. While sequencing for genotype requires 
relatively high coverage, the BSmooth algorithm allows accurate quantitation of 
methylation at base-pair resolution from lower coverage WGBS data by borrowing 
information from neighboring CpGs [45], making WGBS an accessible option for 
analyzing a many kinds of samples. 
Aging 
In humans, aging is the greatest risk factor for disease and morbidity, affecting all 
organ systems in similar and tissue specific ways [46]. Within organ systems, the changes 
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of aging are often explained as a loss of homeostasis arising from altered cellular function. 
In many settings, the cellular changes involve loss of function: in muscles, hair follicles, 
bone and cardiac tissue, cells lose their ability to regenerate tissue [47-50]; in the dermis, 
fibroblasts decrease production of collagen [51]. However, many aging phenotypes are 
also attributed to increased cell activity: there is an increase in cancer and benign 
proliferations and inflammatory cells exhibit higher basal levels of activation [52]. These 
changes are widely attributed to the accumulation of cellular damage over time, but the 
nature of damage and the mechanism of this accumulation remain unclear. 
Both loss and gain of cellular function with aging may be linked to the accumulation 
of senescent cells in tissue. Cellular senescence, a protective response in which the cell 
exits the cell cycle, can be induced in culture by serially passaging of primary cells or as 
an acute stress response (reviewed in [53]). Senescent cells can be visualized in tissue by 
β-gal staining or p16 expression and are observed to accumulate with age in human skin, 
kidney, cardiac, muscle and other tissues [47, 54-56]. Senescent progenitor cells fail to 
properly regenerate tissue, leading to many loss of function phenotypes [47]. Further, the 
presence of senescent cells in tissue stimulates local inflammation and tissue remodeling, 
which may lead to many of the hyper-proliferative and inflammatory phenotypes 
associated with age [57-59]. 
In addition to the presence of senescent cells, alterations to chromatin structure and 
other cellular changes contribute to aging phenotypes across many systems. In 2013, Otin 
et al. proposed nine “hallmarks of aging” which demonstrably contribute to lifespan. 
These include genomic instability, telomere attrition, epigenetic alterations, loss of 
proteostasis, deregulated nutrient sensing, mitochondrial dysfunction, cellular senescence, 
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stem cell exhaustion and altered intercellular communication [60]. With regard to 
epigenetic change, decreased global levels and altered distribution of heterochromatic 
marks are associated with aging in c. elegans and drosophila [61, 62]. Functional 
relevance of these changes is supported by studies in which deletion of histone K27 or 
K4 methylation machinery or manipulation of heterochromatin binding proteins directly 
alters lifespan [62-65]. Otin et al. note that, in addition to chromatin changes, consistent 
DNA methylation changes have been observed with mammalian aging, however these 
changes have not yet been directly implicated in regulation of lifespan [60]. These 
observations are discussed in detail below.  
In this work, we focus on two tissues allowing examination of different aspects of 
human aging: human skin, in which the majority of aging phenotypes are driven by UV 
and other environmental exposures, and human peripheral blood, where aging phenotypes 
are primarily attributed to changes in function of the progenitor cell population. Aging in 
both tissues has been extensively studied, below is a brief introduction to the changes that 
have been observed in each setting. 
Aging in human skin  
Mammalian skin consists of two layers. The superficial layer, the epidermis, is 
approximately 60 µm thick and consists of stratified layers of keratinocytes, regenerated 
by the basal layer. In addition, for approximately every 36 keratinocytes, there is 1 
melanocyte and for every 53 keratinocytes, there is 1 Langerhans cell [66]. Melanocytes 
are found within the basal layer and produce melanin pigment, which spreads through the 
epidermis and acts as both a physical barrier to UV penetration of the skin and as a 
scavenger of reactive oxidative species [67, 68].  The Langerhans cells are immature 
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dendritic cells that internalize foreign proteins and act as antigen presenting cells. The 
deeper dermal layer consists of a dense matrix of connective tissue, primarily collagen 
and elastin.  The most prevalent resident cell population in the dermis is dermal 
fibroblasts that produce this matrix.  
Skin aging is intimately entwined with the effects of chronic UV exposure. The 
histological changes associated with aging and sun exposure in skin have been 
extensively studied. The primary histopathological changes associated with aging and sun 
exposure are structural: In the epidermal layer, increased thickness is associated with sun 
exposure; decreased thickness is associated with aging. Within the dermal layer, loss of 
collagen and elastin and altered fibroblast morphology is associated with both 
chronological aging and sun exposure [69, 70]. Both extrinsic and intrinsic skin aging are 
associated with broad changes in gene expression, with many similar pathways 
differentially regulated in each. For example, loss of dermal collagen in both sun-
protected and sun-exposed skin is associated with increased expression of matrix 
metalloproteinases in the epidermis downstream of AP-1 signaling. Nuclear localization 
of AP-1 is activated in sun-exposed skin by UV exposure and is also increased with age 
in sun-protected skin [71]. 
In addition to structural changes, there is evidence of altered function of skin with age. 
Aged skin has decreased barrier function, as evidenced by water loss and permeability, 
and delayed regeneration after wounding [72]. This change is attributed to alterations 
within the extracellular matrix of the dermis, decreased regenerative capacity of 
keratinocytes and altered lipid profiles within the epidermis [72-74].  In parallel to this 
decreased function, there is an increasing risk of skin cancer with age, especially basal 
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cell and squamous cell carcinoma, which arise from the keratinocyte cells of the 
epidermis [75]. 
Aging in human blood 
Peripheral blood consists of multiple cell types regenerated from hematopoietic stem 
cells (HSCs) residing primarily in the bone marrow. The largest population of cells is 
enucleate red blood cells, which function in carrying oxygen to tissues and transporting 
carbon dioxide away from tissues. Within the nucleated cell fraction, the most common 
population is polymorphonuclear neutrophils (~60%), which function in the innate 
immune response. The next most prevalent are lymphocytes (~30%), which function in 
the adaptive immune response. Within the lymphocyte population, there are naïve cell 
populations, which respond to new antigens, and memory cells that mediate quick 
responses to previously encountered antigens. Approximately 5% of cells in the 
peripheral blood are monocytes, which migrate into target tissues and function in the 
innate response in those tissues. Other cell types within the peripheral blood include 
basophils, which release histamine in certain nonspecific immune reactions and 
eosinophils, which respond to parasitic infection. 
Aging in the hematopoietic system is associated with decreased ability to respond to 
new infections, termed immunosenesence [76].  This is linked both to altered 
differentiation capacity of hematopoietic stem cells and altered function of differentiated 
cells. As mammals age, the HSC population increases, however it does not continue to 
replenish all cell types evenly. There is decreased production of lymphocytes and 
increased production of myeloid cells [77, 78]. In addition, lymphocytes present within 
the elderly have a decreased ability to coordinate response to new infection, due to 
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decreases in the number of naïve cells and impaired interactions between mature 
lymphocytes [79].  
In addition to immunosenesence, hematopoietic aging is associated with increased 
basal activation of inflammatory pathways. Older subjects have repeatedly been observed 
to have elevated pro-inflammatory cytokines in serum, the levels of which correlate with 
decreased functional capacity with age [80]. In vivo work indicates this is due in part to 
cell intrinsic changes, as monocytes from aged individuals show increased inflammatory 
cytokine production after stimulation [52] 
DNA Methylation change with aging: 
Both regional and large-scale DNA methylation changes associated with aging 
have been reported in multiple tissues. Before the development of array technology, 
multiple groups reported decreased methylation in repeat elements associated with aging 
of peripheral blood [81, 82]. A study of two family cohorts sampled at multiple time 
points demonstrated change to global methylation levels with age, however the direction 
and magnitude of change was seen to cluster among families, implicating genetic 
influence on global methylation over time [83]. By contrast, an early study of global and 
site specific methylation of monozygotic twins showed a divergence in methylation over 
lifetimes, indicating environmental influence [84].  
The development of array and sequencing technology has allowed more nuanced 
analysis of where in the genome DNA methylation changes with age. An early study 
using the Illumina HumanMethylation27 Beadchip (27k) array, a promoter-biased array, 
identified common sites of differential methylation with age in CD4+ lymphocytes and 
CD14+ monocytes. In this study, age associated hypermethylation occurred preferentially 
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in regions with both repressive and permissive chromatin marks (“bivalent domains”) in 
embryonic stem cells and regions with repressive chromatin marks in differentiated cells 
[85]. The release of the more genome scale Illumina HumanMethylation Beadchip450 
(450k) array has facilitated more thorough observations. 450k array studies in peripheral 
blood, brain and muscle have confirmed the association between hypermethylated age-
DMRs and regions found to have repressive chromatin marks (H3K27 trimethylation and 
H3K9 trimethylation), and have observed that regions hypomethylated with age are 
frequently marked by H3K4 monomethylation [86-88].  
Utilizing the 450k methylation data available from multiple tissues, Horvath 
identified a model using 353 CpGs that is used to calculate a “methylation age”. This age 
correlates strongly with chronological age across a large variety of tissues and cell 
types[89]. The “methylation age” determined by applying this model to peripheral blood 
data was observed to predict with mortality and functional measures [90, 91] and 
accelerates in some systems of accelerated aging [92, 93]. This work suggests that aging 
of the peripheral blood methylome may serve as a marker of biological aging. 
The use of whole genome bisulfite sequencing to study primary tissue across ages 
has been limited, but indicates that more large scale change maybe present. Sorted CD4+ 
cells from one newborn and one centenarian examined by Heyn et al. using whole 
genome bisulfite sequencing (WGBS) showed large scale hypomethylation with age, 
primarily in repeat-rich and gene-poor regions, however the generalizability of this result 
is limited by the use of only one cell type and single donors in each age group [94].  
Intriguingly, widespread blocks of hypomethylation were also observed in vivo in 
fibroblasts cultures to replicative senescence [95]. These findings suggest the early 
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observations of hypomethylated repeat elements with age may be linked to the 
development of hypomethylated regions similar to the blocks observed in cancer. 
  Human skin offers a particularly attractive model for studying the environmental 
contribution to methylation change with aging, however studies of DNA methylation in 
skin aging have been limited. An early study used the 27k array and saw few changes 
associated with either aging or exposure, possibly due to the limited coverage of this 
array [96]. A more recent study used Whole Genome Bisulfite Sequencing (WGBS) to 
examine methylation in aging skin more comprehensively, however they looked only at 
samples from one body site, the inner forearm, of each individual and thus were not able 
to characterize the interaction between intrinsic and extrinsic aging in these samples[97]. 
While changes to the DNA methylome with age have been observed across many 
systems, the underlying mechanism of this change has not been established. Given the 
overlap between age- hypermethylated cytosines and genomic regions marked by H3K27 
and H3K4 trimethylation, it is possible that the age related loss of enzymes placing those 
marks, as observed in flies and c. elegans, leads to DNA methylation changes by altering 
local chromatin structure and/or transcription factor binding. Loss of methylation at the 
large block domains was attributed to altered DNMT1 localization in late passage, 
senescent fibroblasts [95], however the cause of this change and relevance to in vivo 
aging is unknown. 
The functional consequences of the commonly reported age related methylation 
changes are similarly unknown.  While differential methylation between tissues 
correlates with differential gene expression, there is no evidence of this relationship for 
CpGs identified as determining “methylation age” [89].  A study comparing methylation 
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and gene expression of purified monocytes and lymphocytes from older donors further 
demonstrated that regions differentially methylated with age across multiple cell types do 
not show a clear relationship to expression of the nearest gene [98]. In a study of 
hematopoietic stem cell aging, no relationship was seen between regions differentially 
methylated and genes differentially expressed with age in mice. However, that study 
noted that the methylation changes occurred near genes required for downstream 
differentiation, suggesting that differential methylation stem cells may regulate their 
ability to induce appropriate gene expression during differentiation or in response to 
stimuli [99].  
 In this work, we use unbiased, genome-wide methods to characterize DNA 
methylation change with age and investigate the factors underlying widespread change.  
By using the 450k array and WGBS to analyze human epidermal and dermal samples 
from older and younger individuals, we examine the influence of age and sun-exposure 
on the methylome and implicate chronic exposure in widespread epigenomic change.  To 
clarify the cell intrinsic nature of epigenomic change in a non-exposure driven model, we 
perform a multi-scale analysis of DNA methylation in sorted blood cell populations from 
younger and older donors, demonstrating cell type specificity in both global and local 
methylation change with age. Given the widespread changes in methylation observed in 
these systems, we examine growth arrested and dividing cells in culture to determine 
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The material presented in this chapter has been published in Genome Biology 
(Vandiver et al. 2015) and is reproduced in part below. 
Introduction 
Aging is the greatest single risk factor for cancer, cognitive decline, frailty, and 
immunological dysfunction [46], yet consistent genomic alterations related to aging have 
been elusive. For example, few genetic variants regulating human life span have been 
identified [100, 101]. At the same time, there is a growing realization that environmental 
factors are major contributors to aging and age-associated illness. Epigenetics is the study 
of chemical modifications of the genome, heritable by cell progeny, and it has been an 
attractive target for studies of aging and environmentally-influenced disease. Several 
groups have shown differences in DNA methylation—a covalent modification of cytosine 
at CpG dinucleotides—in peripheral blood samples and other tissues with increasing age 
[85, 94, 102]. Some of these differences are possibly confounded by changes in cell type 
distribution with aging [103], but many are likely real as they are seen across multiple 
cell types. Studies of identical twins have shown markedly divergent patterns of DNA 
methylation in whole blood over the lifespan, suggesting an environmental component to 
epigenetic change with age [84], and the epigenetic drift hypothesis [104].  
The skin as a model of aging offers the advantage of studying the influence of 
environmental factors by virtue of its direct exposure to the sun. The superficial layer of 
epidermis (~60 µm) interfaces more directly with the outside world than the deeper 
dermal layer. Even penetration of solar ultraviolet (UV) radiation is mostly in the 
epidermis [105]. Furthermore, skin affords the ability to compare the effects of intrinsic 
and extrinsic (environmental) aging through the comparison of chronically sun-exposed 
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(e.g., forearm and face) and sun-protected skin (e.g., upper inner arm) in the same 
individual. Both layers offer a relatively homogenous system for analyzing DNA 
methylation; the epidermis especially is composed of around 95% keratinocytes [106]. 
Histological changes associated with aging and sun exposure in human skin have been 
extensively studied. The primary histopathological changes associated with aging and sun 
exposure are independent of cell type change: In some studies of the epidermal layer, 
increased thickness is associated with sun exposure, decreased thickness is associated 
with aging. Within the dermal layer, loss of collagen and altered fibroblast morphology is 
associated with both chronological aging and sun exposure [69, 70]. Despite the lack of 
large cell type shifts, both extrinsic and intrinsic skin aging are associated with broad 
changes in gene expression, with many similar pathways differentially regulated in each. 
Pathways associated with intrinsic aging in sun-protected skin are seen to be amplified by 
chronic environmental exposure in sun-exposed skin [71, 107]. We therefore 
hypothesized that epigenetic changes might mediate the changes associated with 
environmental exposure in aging skin.  
A previous study of DNA methylation in aging skin tissue was limited 
technologically. This study used the Infinium HumanMethylation27 BeadChip which 
measures 27,000 CpG sites, focused on dense CpG regions termed CpG islands [96]. It 
showed little change related to skin aging (hypermethylation at 0.38% of sites) and even 
less change associated with sun exposure (hypomethylation at 0.05% of sites)[96]. We 
and others have recently observed widespread differentially methylated regions (DMRs) 
across the genome that distinguish tissues (t-DMRs), stages of stem cell reprogramming 
(r-DMRs), and cancer (c-DMRs). Most of these alterations are either at regions near but 
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not in CpG-dense islands, termed CpG island shores, or distal from both islands and 
shores (the “open seas”) [25, 26, 28, 32]. These distal regions were discovered to be large 
blocks, corresponding to heterochromatin regions termed large organized chromatin 
lysine-modifications (LOCKs) or nuclear lamin-associated domains (LADs), and these 
large blocks show substantial hypomethylation in cancer [28, 108]. Almost none of these 
regions is represented on the Infinium HumanMethylation27 BeadChip, and thus were 
not included in the previous study. A more recent study used Whole Genome Bisulfite 
Sequencing (WGBS) to examine methylation in aging skin more comprehensively, 
however they looked only at samples from one body site, the inner forearm, of each 
individual and thus were not able to characterize the interaction between intrinsic and 
extrinsic aging in these samples[97]. 
In order to more fully examine methylation in human skin samples affected by 
age and sun-exposure, we performed array-based DNA methylation analysis using the 
Infinium HumanMethylation450 BeadChip array, which includes islands, shores, most 
known c-DMRs, t-DMRs, and r-DMRs and probes within the “open sea” regions 
identified as part of the hypomethylated blocks in cancer [109]. We applied recently 
developed algorithms [110] capable of identifying differences in large blocks as have 
previously been detected in cancer samples using whole genome bisulfite sequencing 
(WGBS), and we confirmed these results directly with WGBS of additional samples. 
Here we describe profound changes in DNA methylation associated with combined aging 
and sun exposure, involving 670 Mb of the genome, and including large blocks similar to 
cancer. In human subjects, these changes are progressive with quantitative measures of 
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skin aging. These same blocks are observed to be hypomethylated in squamous cell 
carcinoma samples. 
Results  
We undertook a comprehensive genome-wide analysis of DNA methylation in 
human skin to test specifically for alterations associated with age or with sun exposure, 
and the potential relationship between these regions. Ten younger individuals (<35 years 
old) and 10 older individuals (>60 years old) each submitted one sun-protected biopsy 
specimen from the upper inner arm, as well as one sun-exposed specimen from either the 
dorsal forearm or crow’s feet (lateral epicanthus) (donor information in Table 1.1). 
Donors were carefully selected to exclude individuals with active skin conditions or 
individuals using topical medications (exclusion criteria detailed in methods). As 
methylation and sun-exposure effects both vary with race, we limited this sample set to 
Caucasian donors. In addition to tissue biopsies, donors volunteered health history 
information. For each donor, a dermatologist evaluated their degree of apparent skin 
aging in both sun-exposed and sun-protected regions using two established scales.  
In order to study more homogenous tissue samples, each punch biopsy was 
mechanically separated into epidermis and dermis following overnight incubation with 
dispase, a procedure associated with unappreciable fibroblast contamination in cultured 
epidermal sections [111], and analyzed separately. In previous work, epidermal sections 
separated in this manner show the same age and sun exposure related methylation 
changes as epidermal sections separated by suction blister, indicating the dispase 
separation does not have significant effects on the methylome [96]. To confirm 
uniformity of our technique among sample groups, we sectioned a subset of dispase 
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separated epidermal layers and performed hematoxylin and eosin staining.  Examination 
of stained sections showed separation below the basal layer for all age and sun exposure 
groups, consistent with previous histological analysis of dispase separated epidermis 
(Figure 1.1) [112]. To characterize methylation genome-wide, we used the Infinium 
HumanMethylation450 bead chip, which includes most CpG islands and shores, 
additional regions shown to be differentially methylated in cancer and development, and 
other functionally important regions [109].  
We classified the samples from each skin layer into four groups: younger sun-
protected (Y-pro), younger sun-exposed (Y-exp), older sun-protected (O-pro), and older 
sun-exposed (O-exp). To obtain an overview of the genome-scale differences among 
these eight groups, we performed principal component analysis and created scatter plots 
of the first two principal components. As expected given the established differential 
methylation between tissue types [25], the greatest differences were between dermis and 
epidermis, supporting the experimental rationale of dissociating those two tissues. There 
was also clear separation between samples obtained from either sun-protected or sun-
exposed arm and from the face, indicating that this anatomical difference had to be 
considered during subsequent analysis. When a principal component analysis was 
repeated with just the epidermal arm samples, there was striking separation among the 
four groups, with the greatest difference between O-exp and Y-pro (Fig 1.2A). The sun-
exposed samples obtained from the face cluster separately, however maintain the 
separation between old and young. Principal component analysis on dermal arm samples 
did not show separation related to age and exposure (Fig 1.2B), suggesting that the 
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number of differences would be much less than in epidermis, consistent with the previous 
studies[96]. 
Hypomethylated blocks associated with aging and sun exposure in epidermis 
In previous studies comparing methylation in colorectal cancer and normal 
samples, large hypomethylated blocks spanning large, primarily CpG-poor regions of the 
genome were seen to be the major source of methylation change in cancer [28, 108]. 
Given the large differences found by principal component analysis within epidermal 
samples, we hypothesized that similar large blocks might underlie the methylation 
changes seen with age and sun exposure. Recent advances in analysis of 450k data 
through the Minfi package now make it possible to identify such large blocks in addition 
to small differentially methylated regions by applying the Bumphunter approach to 
probes in open sea regions using a large smoothing window [110, 113]. We began by 
using this block finder to identify any large blocks differentially methylated between the 
samples that appear most different upon principle component analysis, the epidermal O-
exp and Y-pro samples. Sun exposed samples obtained from the face were included in 
this analysis. Identified blocks were filtered by size and the calculated family-wise error 
p-value. We identified 224 blocks, of which 223 were hypomethylated in the O-exp 
samples compared to Y-pro samples, with an average size of 443 Kb (ranging from 202 
Kb to 1.3 Mb) and 9.2% reduction in DNA methylation, ranging from 5.2-16% 
(examples in Fig 1.3A and Fig 1.3B, list of block locations in Table 1.2). These blocks 
cover a total of 99 Mb of the genome. It is likely that more blocks of hypomethylation are 
present in these samples, however our detection is limited by the coverage of the 450k 
array in open sea regions.  
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We first sought to rule out confounding by the fact that exposed and protected 
samples are obtained from slightly different sites on the body (outer arm vs. inner arm). If 
the large scale differences observed were due to body location per se and not chronic 
exposure, we should detect these changes comparing the exposed and protected samples 
obtained from younger individuals. To address this, we performed the block finding 
analysis comparing Y-exp and Y-pro samples. Using the same cutoffs applied previously, 
we identified only 12 regions that differ, encompassing 3.8 Mb of the genome—
compared to 224 regions, encompassing 99 Mb for the O-exp vs. Y-pro comparison 
(Table 1.3). While significant, the relatively small area involved (3.8Mb compared to 99 
Mb) indicates the magnitude of block hypomethylation observed comparing O-exp and 
Y-pro samples cannot be attributed only to body site differences. By contrast, when 
comparing the O-exp and O-pro samples, we identified hypomethylated blocks of a 
comparable magnitude to the O-exp and Y-pro comparison, 239 blocks encompassing 
100Mb, with a mean difference of 8.6% hypomethylated. While these analyses were 
performed without regard to individual specific changes, comparing the paired and 
unpaired t-statistics for each methylation location demonstrates that the unpaired analysis 
is conservative and only underestimates the magnitude of change present (Figure 1.4).  
This further indicates that only long term sun-exposure, as seen in older donors, is 
sufficient for hypomethylated blocks.  
We also sought to determine if hypomethylation at specific regions may be linked 
to age alone by comparing O-pro and Y-pro samples. However, using the cutoffs applied 
previously, no blocks were detected. This is consistent with the lack of large scale change 
associated with intrinsic aging reported previously[96]. By contrast, when we compared 
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O-exp and Y-exp samples, we identified 33 block regions with an average of 10% 
difference in methylation, 32 of which are hypomethylated age, encompassing 12.7 Mb 
(Table 1.4). The presence of age-related hypomethylated blocks in the sun exposed body 
site but not the sun protected body site further demonstrates that hypomethylated blocks 
arise only in epidermal tissue affected by both aging and sun exposure. In contrast to the 
epidermis, all block finding comparisons in the data from dermal samples identified no 
significant blocks, consistent with the lack of differential clustering seen in the principal 
component analysis. Thus, hypomethylated blocks encompassing a significant portion of 
the genome are only observed in epidermal samples affected by both age and sun 
exposure. Results of all comparisons are summarized in Table 1.5. 
Hierarchical clustering of all 38 epidermal samples based on methylation within 
identified blocks demonstrated a progressive hypomethylation with age and sun 
exposure: the Y-pro samples are most methylated in blocks; O-pro and Y-exp samples 
have lower block methylation; and O-exp samples have the lowest methylation in 
identified blocks (Fig 1.3C). Furthermore, this showed individual variation in the 
magnitude of change in blocks, with some donors showing much larger changes than 
others.  For example, donor 8 has the lowest methylation in the sun-exposed sample 
across most identified blocks, while the sun exposed sample from another older 
individual, donor 16, is more methylated within the identified blocks. Sun-exposed 
samples obtained from the face (denoted in Figure 1.3C) fall with sun-exposed samples 
obtained from the arm, indicating that the observed hypomethylation is not specific to the 
dorsal forearm.  
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Confirmation of hypomethylated blocks by whole genome bisulfite sequencing  
To confirm the presence of hypomethylated blocks related to age and sun 
exposure in epidermal tissue and to examine the whole genome, we obtained sun exposed 
and sun protected epidermal tissue from 3 additional younger donors (mean age 22 years, 
average Griffiths’ grade 0) and 3 additional older donors (mean age 77 years, average 
Griffiths’ grade 5) and performed whole genome bisulfite sequencing (WGBS). We 
generated sequencing data to a depth of 5.6x-7.2x and analyzed it using the BSmooth 
algorithm, which was designed for analyzing low-coverage WGBS data and has been 
previously demonstrated to accurately estimate methylation levels at a single-base pair 
resolution by borrowing information from nearby CpGs [45]. After filtering reads with 
low quality measures, we obtained measurements for an average of 24,873,842 CpGs per 
sample (average of 88.15% coverage). Bisulfite conversion, assessed using spiked in 
lambda phage, ranged from 99.7-99.9% (Details in Methods, Tables 1.6,1.7). 
We first examined CpGs within the regions identified as blocks comparing the O-
exp and Y-pro samples in 450k. All 450k O-exp/Y-pro blocks showed hypomethylation 
in the O-exp samples in WGBS data, with 185/224 blocks showing >5% mean 
hypomethylation in O-exp samples in the sequencing data, validating our finding of 
widespread hypomethylated blocks in O-exp epidermis. For block regions depicted in 
Figure 1.3A and 1.3B, methylation in WGBS samples is shown in the lower panel. Mean 
methylation difference from WGBS for all 450k blocks is indicated in Table 1.2. When 
only methylation within blocks identified in 450k data was examined, we observed 
separate clustering of O-exp samples from Y-pro samples, indicating these regions are 
sufficient to differentiate groups within sequencing data (Figure 1.5).  
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Density plots of measured methylation at all CpGs with sufficient coverage in all 
sample groups showed hypomethylation in sun-exposed epidermal samples from older 
donors (Fig 1.6A). Using BSmooth [45], we identified blocks within our WGBS dataset. 
As in 450K data, we identified large regions of change comparing the O-exp and Y-pro 
epidermal samples. The bisulfite sequencing analysis identified a similar mean loss in 
DNA methylation, 9% (ranging from 5-23%), but a much more substantial fraction of the 
genome than found by 450K analysis, i.e. 670 Mb (21% of the genome). The mean loss 
in methylation comparing the more closely related groups found similar reductions in 
mean methylation but fewer numbers of blocks than in 450K analysis, likely because of 
the smaller sample size for sequencing and thus reduced power to detect differences 
between the more closely related groups in the latter case (summarized in Table 1).  
The observed global hypomethylation in O-exp samples is explained by CpGs 
within the identified blocks (Fig 1.6B and 1.6C). Thus, the results of this replication set 
independently confirmed our finding of hypomethylated blocks in samples affected by 
age and sun exposure. Examples of block regions identified in WGBS are shown in 
Figure 1.6D.  
Hypomethylated blocks overlap with heterochromatic domains 
The increased genomic coverage provided by sequencing data allowed us to 
compare the identified regions to other genomic domains identified through sequencing-
based methods. The hypomethylated O-exp vs. Y-pro blocks in our data were seen to 
overlap strongly with previously reported hypomethylated blocks in human colon cancer 
[114] (odds ratio 8.5, p < 2 x 10−16). These O-exp vs. Y-pro blocks similarly showed 
significant overlap with Large Organized Chromatin K (lysine) methylation 
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heterochromatin domains (LOCKs) (odds ratio 3.4, p < 2 x 10−16) and with lamin-
associated domains (LADs) (odds ratio 3.5, p < 2 x 10-16) mapped in fibroblast cell lines 
[29, 114]. Similar overlap of hypomethylated domains with these heterochromatin 
structures has been described in cancer and EBV-transformation of lymphocytes [28, 
114], suggesting a functional connection between the age and exposure associated 
alteration in large domains of DNA methylation and processes related to cancer.  
 In other studies, small age-related DMRs have been found to occur preferentially 
at regions marked by both H3K4me3 and H3K27me3 in embryonic stem cells (bivalent 
domains) [85, 115]. We compared the identified blocks to regions identified as containing 
both H3K4me3 and H3K27me3 in human embryonic stem cells [116] and saw no 
enrichment (odds ratio 0.68, p < 2 x 10−16). Further, we note that only 17 out of 353 of 
the CpGs seen to correlate strongly with chronological age across multiple tissues by 
Horvath [89] are found within the identified block regions. This suggests that the 
observed large regions of hypomethylation in aged, sun-exposed epidermis represent a 
distinct change from the chronological age specific changes reported across other studies.  
Methylation in blocks associated with clinical measures 
Given the observed individual variation, we sought to determine how well block 
methylation levels predict clinical changes associated with skin aging. For each skin 
donor, a dermatologist evaluated their degree of apparent skin aging in sun-exposed and 
sun-protected regions using two established scales. Griffiths’ photodamage age grading 
measures coarse and fine wrinkling, photopigmentation and yellowing [117], and showed 
a significant correlation with mean block methylation in sun-exposed epidermal samples 
(R2 = 0.61, P<0.001) (Fig 1.7A). Much of the variation in this relationship appears to be 
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linked to the younger, sun-exposed samples obtained from the face, which appear to be 
more hypomethylated for a given age grade than the arm samples. When these samples 
are removed from regression, correlation is even stronger, with an R2=0.81, p-value 
<0.001 (Fig 1.3D). Helfrich’s photo-protected skin aging scale, in contrast, was 
developed for sun protected skin and measures more nuanced fine wrinkling [118]. This 
sun-protected scale showed far less pronounced correlation with block methylation in 
sun-protected samples (R2=0.16, P=0.1) (Fig 1.7B), suggesting that the block 
hypomethylation correlates with clinical grading primarily in epidermal samples affected 
by sun exposure. Thus, methylation levels in O-exp vs. Y-pro blocks decrease with 
chronic exposure, varying with the degree of clinically appreciable photoaging. 
To explore how genetic diversity may relate to the observed hypomethylated 
blocks in aged, sun-exposed skin, we examined signal at 65 single nucleotide 
polymorphism (SNP) probes included on the 450k array. None of the 65 probes showed a 
significant difference (adjusted p-value<0.05) between samples from older and younger 
individuals, even though these probes were chosen to discriminate genetic structure[109]. 
Additionally, we compared identified block regions to the genetically controlled 
methylation clusters (GeMes) mapped in a recent work using data from two large 
Caucasian cohorts[119], and genetically controlled CpGs identified using a large cohort 
of female twins through the MuTHER study [120]. 84 of the identified O-exp vs. Y-pro 
blocks contain GeMes, however the GeMes account for only 6.6 Mb of the identified 99 
Mb, indicating that a large area is involved in which methylation is not directly linked to 
genotype. Similarly, of the 13,378 probes involved in our identified O-exp vs. Y-pro 
blocks, only 3,236 were linked to genotype. GeMes within the identified blocks are 
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denoted in Table 1.2. Furthermore, if the effect observed were genetically driven, 
hypomethylated blocks would be present in both samples obtained from the involved 
individuals, but they are found only in older, sun-exposed samples.  
 Given previously reported relationships between DNA methylation and body 
mass index (BMI) and smoking [120-122], we compared methylation levels within the 
identified blocks to BMI and between smokers and non-smokers. We observed no 
significant relationship between BMI and block methylation (R2 = 0.02, p=0.56) or 
smoking status for donors for which this information was available (R2 = 0.20, p=0.32) 
(Fig 1.8A and 1.8B). 
Differentially expressed genes within hypomethylated blocks 
 To determine the relationship between hypomethylated blocks observed in 
epidermal samples with sun exposure and aging, we obtained RNA from epidermal 
samples from a subset of the donors, including 3 Y-pro epidermal samples and 4 O-exp 
epidermal samples (individual donors used denoted in Table 1.1). Expression data was 
obtained using Affymetrix arrays.  When we compared O-exp and Y-pro samples using 
Gene Set Enrichment Analysis (GSEA) [123], 88 pathways were identified as 
significantly enriched based with an FWER < 0.05. Intriguingly, this analysis identified 3 
pathways associated with UV exposure in vitro, as well as multiple pathways linked to 
cell cycle and proliferation (full results in Table 1.8). To understand the relationship 
between sample groups, we used limma to compare each group of samples.  When 
comparing the O-exp and Y-pro samples, we observed more probes with upregulation in 
the O-exp samples (Fig 1.9A and 1.9B). When we considered the intrinsic aging 
comparison (O-pro vs Y-pro), we did not observe this trend (Fig 1.9C and 1.9D). When 
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we considered the Y-exp vs Y-pro comparison, we noted a similar trend towards 
upregulation in the sun exposed samples (Fig 1.9E and 1.9F).  This indicates that, unlike 
the pattern observed with methylation, the global changes in gene expression are driven 
by the exposure/body site differences, not the combination of age and sun exposure. 
 Given our observation of widespread methylation changes within the epidermal 
samples, we sought to use our gene expression data to confirm that no large shifts in cell 
type composition may be confounding our analysis.  The second most common cell type 
in the epidermis, melanocytes (~3% of cells), can be distinguished from keratinocytes 
based on the presence of MITF and SOX10 [124]. To determine if large changes in 
melanocyte levels are present in our samples, we examined expression probes measuring 
expression of these markers (3 measuring MITF and 2 measuring SOX10).  None of the 
examined probes showed a significant difference in expression comparing O-exp and Y-
pro samples, and none showed a log fold change greater than 0.5 (Fig 1.10). 
In order to determine how patterns of expression relate to the identified 
hypomethylated blocks, data was normalized using fRMA and probes were classified as 
expressed or unexpressed using gene expression barcode [125]. When expression data 
was compared to the locations of photoaging blocks, probes within blocks were less 
likely to be expressed than those outside (OR 0.38, p<0.001), consistent with the 
observed overlap between blocks and heterochromatic regions.  
Blocks hypomethylated with sun-exposure and aging are hypomethylated in squamous 
cell carcinoma  
Having observed an overlap between our chronic exposure blocks and 
hypomethylated domains observed in colon cancer, we sought to determine the relevance 
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of our identified domains to a cancer that develops in epidermis with chronic sun 
exposure, squamous cell carcinoma (SCC). We obtained 7 SCC tissue samples and 6 
normal skin samples from the same body sites as the SCC samples and analyzed DNA 
methylation using the 450k array. Strikingly, we observed hypomethylation of SCC 
samples compared to normal samples when examining probes within the identified 
chronic exposure blocks (Fig 1.11A), which is not seen when examining probes outside 
of these regions (Fig 1.11B). This difference is seen even when examination is limited to 
probes within the constitutively methylated open sea probes (Fig 1.11C and 1.11D). For 
221 out of 223 identified hypomethylated blocks, SCC samples had lower mean 
methylation than normal samples (difference in mean methylation noted in Table 1.2). 
Clustering of this data based on mean methylation within identified photoaging blocks 
distinguishes most SCC from normal samples (Fig 1.11E). 
Methylation age correlates strongly with chronological age 
In a recent work, Horvath built an age-prediction model using methylation at 353 
cytosines probed on the 450k array which allows calculation of a “methylation age” for 
any given sample[89]. Horvath reports these methylation ages are highly correlated with 
chronological age using a wide range of tissue samples.  We applied Horvath’s model to 
calculate methylation age for our samples to determine how the widespread 
hypomethylation we observe in O-exp epidermis relates to methylation age.  We 
observed a strong correlation between chronological age and methylation age for both 
dermis (R2=0.91, p<2.2e-16) and epidermis (R2=0.83, p<1.1 e-15) (Fig 1.12).  
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Small differentially methylated regions overlap with polycomb targets 
We next used our 450k data to identify small differentially methylated regions. 
We used the method of “bump hunting,” which identifies genomic regions in which 
methylation levels at consecutive measured locations are associated with the outcome of 
interest. That method was initially developed for the CHARM array based methylation 
method but was adapted for the Minfi package for the 450K array [110, 113]. 
Significance testing was performed by permutation analysis. Comparing O-exp and Y-
pro epidermal samples, we identified 166 small DMRs with at least 10% difference in 
methylation and an adjusted family wise error rate <0.1. These included 90 
hypermethylated and 76 hypomethylated DMRs (list in Table 1.9). The average size of 
these DMRs was 460 bp, and the average change in methylation was 37% (ranging from 
23-64%), indicative of local regional effect on DNA methylation, similar to what is seen 
in tissue and cancer DMRs.  
  As we considered with the block regions, we asked what changes were specific to 
age or sun exposure. Similarly to the block analysis, we identified a considerably smaller 
number of DMRs specific to sun exposure (30 significant DMRs found comparing Y-exp 
and Y-pro samples vs. 166 comparing O-exp and Y-pro) and specific to age (2 significant 
DMRs found comparing O-pro and Y-pro samples vs. 166 comparing O-exp and Y-pro).  
Within dermal samples, we again identified fewer regions of change than in the 
epidermis: 9 significant O-exp and Y-pro DMRs were found, with even fewer sun-
specific and age-specific DMRs. Complete DMR counts from all comparisons are shown 
in Table 1.10. These results suggest that small DMRs, like blocks, require both age and 
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sun exposure and occur predominantly in the epidermis, although the cumulative size of 
these DMRs was less than 1% of the area covered by large blocks on 450k.  
In other studies, small age-related DMRs have been found to occur preferentially 
at regions marked by repressive chromatin, bivalent domains, and targets of Polycomb 
Repressive Complex 2 [85, 115, 126, 127]. To determine if this overlap is found in the 
identified small DMRs, we compared the identified regions to regions marked by 
H3K4me3 and H3K27me3 in normal human epidermal keratinocytes (NHEK cells) as 
identified by the ENCODE project [128]. To control for the background enrichment from 
the 450k array, we determined the significance of identified overlaps by generating 
length and probe number matched random regions from all array probes. We called an 
overlap significant if there was more overlap between identified DMRs and chromatin 
mark than >95% of randomly generated region sets. We observed a significant overlap 
between hypermethylated O-exp and Y-pro DMRs and regions marked by H3K27me3 in 
NHEK cells, but not regions marked by H3K4me3. Hypomethylated OE-YP DMRs did 
not overlap significantly with either mark. 
Discussion 
 In summary, a comprehensive analysis of DNA methylation in aging and sun-
exposed skin reveals widespread DNA hypomethylation of large blocks that overlap 
heterochromatin domains and nuclear lamin-associated domains. The greatest difference 
was between older, sun exposed and younger, sun protected epidermal samples, with 
indicating that both age and sun exposure status is necessary for widespread 
hypomethylation. We further observe these same regions to account for the majority of 
the hypomethylation in squamous cell carcinoma samples, suggesting a possible link 
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between widespread hypomethylation in cancer and the changes observed in normal 
epidermis. 
The most unexpected result of our analysis was the genome-scale differential 
methylation seen in epidermal samples affected by both age and exposure, as evidenced 
by the distinct clustering in principal component analysis. While most population studies 
of aging and environmental exposures have focused on methylation changes in single 
CpGs or small differentially methylated regions [85, 89, 102], here we identify changes 
across large block regions encompassing ~20% of the genome. This extent of altered 
methylation suggests that the change associated with chronic environmental stress should 
be studied on a genome scale, rather than only focusing on changes in DNA methylation 
in discrete regions. While our sample size relatively small, the large scale change 
identified is informative for future study. The overlap of our identified blocks with other 
structural domains, including LADs and LOCKs, further supports the idea that the 
observed changes in DNA methylation are indicative of alteration to the epigenomic 
structure. Future studies of chronic exposure should examine methylation at a similar, 
genome, scale to determine if the changes identified in our sample set are more broadly 
relevant. 
We chose to examine skin in this study because it offers a relatively homogenous 
system with regard to cell type for studying aging and exposure. Once separated, the 
epidermis in particular consists of 90-95% keratinocytes in both sun-exposed and sun-
protected body sites[106]. The other main cell types in the epidermis, melanocytes and 
Langerhans cells, account for a small percentage of cells—there are approximately 36 
keratinocytes per melanocyte and approximately 53 keratinocytes per Langerhans 
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cell[66]. While small increase in melanocyte density in sun-exposed body sites and small 
decreases in melanocyte density with age have been reported, these are not of the correct 
pattern or sufficient magnitude to confound the observed blocks of hypomethylation: 
comparing sun-exposed and sun-protected body sites from young and old individuals 
shows up to a twofold increase in melanocytes in heavily sun-exposed sites and a 
decrease in melanocyte density by 6-8% per decade in both sun-exposed and sun-
protected locations[129]. The consistent level of expression of melanocyte markers 
within our sample set confirms that no unexpected large changes in melanocyte 
composition are present in our study. As melanocytes account for ~3% of cells present, a 
doubling or complete loss of these cells could account for up to a 3% change in 
methylation, smaller than the magnitude of change observed in blocks. Further, as we 
demonstrate, the observed hypomethylated blocks are not present comparing sun exposed 
and sun-protected body sites in young individuals, so they can not be attributed to the 
increased percentage of melanocytes present in sun exposed body sites of both young and 
old individuals. The age related decrease in melanocytes would amount to approximately 
a 1% change in cell composition over 4 decades (32% decrease in 3% of cells), which is 
again, not sufficient to account for the changes we observe. Consistent with the very 
small changes in cell composition reported in the literature, analysis of gene expression 
data from our samples indicates no significant changes in melanocyte marker genes. 
In the recent literature, multiple methods have been developed to in silico correct 
for cell type heterogeneity, including SVA, EWASher and refFreeEwas[130-132].  All of 
these methods assume that the signal between cases and controls is small compared to the 
effect of cell type heterogeneity and that any large scale change identified in principle 
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component analysis is due to cell composition changes. Using these methods will 
therefore remove any large scale signal between cases and controls, even if these 
differences are not due to cell composition effects. An example is given by the EWASher 
paper in which applying the methodology to comparison of colon cancer tumors and 
normal colon leaves only 2 CpGs identified as significantly differentially methylated in 
cancer, contradicting 25 years of literature on this disease[131], and acknowledged by the 
authors themselves to be a significant blind spot of such correction methods [110, 133]. 
Despite the significant body of evidence supporting the absence of large scale cell 
composition changes in our samples, the methylation changes we describe encompass a 
large portion of the genome and are large enough to affect clustering (Figure 1), so it is 
not surprising that the application of these algorithms to our data removes the widespread 
hypomethylation observed in the old, sun exposed samples. However, given the 
substantial evidence indicating no large changes in cell composition with aging and sun-
exposure, we attribute this to the degree of differential methylation within the 
keratinocyte population and not changes in cell type composition.  
The identified blocks are distinct from the single CpGs used to calculate 
“methylation age” by Horvath and the small hypermethylated DMRs overlapping 
bivalent chromatin domains identified as markers of chronological age in other studies 
[85, 89, 115]. We see no evidence of hypomethylation within our blocks or within 450k 
open sea probes associated chronological aging in publically available data from adipose 
tissue or peripheral blood [102, 120], reinforcing our finding that block hypomethylation 
in epidermal tissue occurs only with chronic exposure, not aging alone. Heyn et al. report 
widespread hypomethylation with age in CD4+ T cells from WGBS of cells sorted from 
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one newborn and one centenarian [94], indicating that large blocks of hypomethylation 
may be relevant in other models of aging, however we see only a moderate overlap of our 
identified blocks with hypomethylated CpGs in their study (OR= 1.77) and the use of 
single samples in that study makes it difficult to draw further conclusions about the 
regions involved.   
A functional role of altered block methylation is supported by the correlations 
between block methylation and clinical measures of skin aging. Our analysis of the 
relationship between hypomethylated blocks and gene expression is limited by the low 
number of samples available for gene expression analysis. In studies of cancer and EBV 
transformation, large publically available expression datasets have allowed identification 
of a clear relationship between hypomethylation and variability of expression of genes 
within blocks[28, 114]. Another recent study linked loss of methylation in gene poor 
regions with activation of distal enhancers, indicating that loss of methylation may have 
functional consequences beyond regulation of nearest genes[134].  Consistent with an 
environmental exposure-driven effect, the magnitude of age and sun related change was 
greater in epidermal samples compared to the dermal samples. These results suggest that 
molecular aging and UV exposure studies focused on dermis or full thickness biopsy may 
miss the relevant epigenetic effects [135]. 
 The occurrence of blocks of hypomethylation related to age and sun exposure in 
regions previously seen to be hypomethylated in cancer is highly intriguing. Similar 
blocks identified in colon cancer samples were seen to develop very early in cancer 
progression [28], suggesting epigenetic reorganization may be an early event in 
carcinogenesis. While the blocks observed in our study encompass a smaller portion of 
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the genome and have a smaller magnitude of change, their occurrence in non-malignant 
tissue suggests that epigenomic change may be initiated by exposures, rather than only 
during oncogenesis. Our observation in this work, that blocks identified as 
hypomethylated with chronic exposure in non-malignant tissue are hypomethylated in 
squamous cell carcinoma, while most other sites are not, suggest that these changes may 
occur prior to malignancy.  Our identification of this subset of the “cancer-blocks” that 
become hypomethylated with chronic exposure offers a potential target for 
chemoprevention strategies.  
 We note that these results suggest that an early change quantitatively related 
chronic exposure in skin is a large-scale epigenomic alteration that was missed by earlier 
studies focused on individual genes or loci such as CpG islands. Intriguingly, a recent 
study by Cruickshanks et al. identifies similar large regions of hypomethylation in cells 
cultured to replicative senescence [95], linking such loss of methylation to cell turnover 
and cell stress in culture. Further, Takeuchi et al. recently demonstrated that repeated 
exposure of aged cells to UVA induces expression of progerin, the mutated form of 
Lamin A seen in Hutchinson-Guilford progeria, and abnormal nuclear morphology [136]. 
This is intriguing given the observed overlap between our blocks and lamina-associated 
domains. While speculative, a general model consistent with these data is that repeated 
stress and cell turnover leads to progressive destabilization of heterochromatin along the 
nuclear membrane, with attendant changes in DNA methylation. These changes could 
serve both as a molecular epigenetic clock of environmental exposure and a potential 
target of increased risk. They fit well an age-associated epigenetic drift hypothesis [104]. 
These results may have therapeutic implications. For example, future experiments should 
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be performed to determine whether modifiers of sun damage such as retinoic acid, or 
specific inhibitors of laminopathies such as lonafarnib [137] might modify the 
development of the epigenomic alterations described here. Finally, we emphasize that the 
changes observed here may be restricted to the specific sample types and method of 
analysis used here. 
Experimental Procedures 
Human subjects and tissue samples: Twenty-six healthy volunteers took part in 
the study. Samples from twenty of these donors were used for 450k analysis, and samples 
from the additional six donors were used for WGBS. All participants provided written 
informed consent, and this study was approved by the Johns Hopkins Medicine 
Institutional Review Board (IRB# NA_00041408 for sun-exposed and sun-protected 
samples, NA_0036868 for SCC samples). All human experimentation was performed in 
accordance with the Declaration of Helsinki. Exclusion criteria included use of topical 
medications within 2 weeks of sampling, active or dormant skin conditions, and 
pregnancy. To control for pigmentation, only Caucasian subjects were selected. For each 
subject, a dermatologist evaluated the degree of apparent skin aging using two 
established scales: Griffiths’ photodamage age grading measures coarse and fine 
wrinkling, photopigmentation and yellowing [117] while Helfrich’s photo-protected skin 
aging scale, in contrast, was developed for sun protected skin and measures more 
nuanced fine wrinkling [118]. Paired punch biopsy samples, 4 mm in diameter, were 
collected under local anesthesia from the outer forearm or lateral epicanthus (sun-
exposed area) and upper inner arm (sun-protected area). Immediately after removal, 
samples were washed in PBS and transferred to DMEM (Gibco) containing dispase (2 
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U/mL). Following dispase treatment overnight at 4°C, epidermis and dermis were 
separated, flash frozen and stored at -140°C. SCC containing tissue was obtained from 
ten previously diagnosed patients (8 females and 2 males; median age 67yrs) undergoing 
either Mohs micrographic or excisional surgery for treatment of their skin cancer. During 
repair of the surgical defect, standing cone deformity “dog ear” tissue was retained and 
submitted as normal control tissue. Samples were OCT embedded, frozen and stored at -
80°C. 
Histology: Dispase separated, flash frozen epidermal sections were cut into 5 um 
sections and stained with hematoxylin and eosin.  Sections were imaged using a Vectra 
Imaging system.  
DNA isolation: DNA was isolated from biopsy samples (epidermis and dermis) 
and SCC samples using the MasterPure DNA Purification Kit (Epicentre) according the 
manufacturer’s protocol.  
450k Array: DNA was quantified using Quant-iT Picogreen Reagent (Invitrogen) 
according to manufacturer’s instructions. 1 µg of DNA was bisulfite treated using the EZ 
DNA methylation kit (Zymo Research) according to the manufacturer’s specifications for 
the 450k array. Converted genomic DNA was eluted in 22 µl of elution buffer. DNA 
methylation level was measured using Illumina Infinium HD Methylation Assay 
(Illumina) according to the manufacturer’s instructions.  
450k Analysis: All analyses were performed using R 3.0.3. Raw intensity files 
were obtained and processed using the Minfi package to obtain methylation ratios (Beta 
values). Samples were normalized using the Illumina preprocessing method implemented 
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in Minfi. We applied multiple quality control measures to remove questionable arrays or 
probes. We examined 450k array control probes to assess many measures of assay 
efficiency and calculated median methylated and unmethylated measurements for each 
sample. We removed probes that had an annotated SNP (dbSNP137) at the single base 
extension or CpG site (17541 probes removed). 
To identify blocks, we used the block finder as described elsewhere [110]. Briefly, 
we applied the Bumphunter approach to the open sea probes using a large smoothing 
window. The estimates were thresholded based on a 5% difference in methylation beta 
values. Blocks were filtered to include only those >200 kb. Significance was assigned 
based on permutation testing; a cutoff of adjusted p-value (Family wise error rate) < 0.05 
was used.  
To identify small DMRs, we used the bump hunting technique as previously 
described [138]. Estimated differences were controlled for sex and body site (face or arm) 
in the linear model. The estimates were thresholded using a 0.1 difference in beta values 
(~10% difference in methylation). Significance was assigned based on permutation 
testing; a cutoff of adjusted p-value (Family wise error rate) < 0.1 was used. 
To examine overlap with histone marks, we downloaded ChIP-Seq peaks from 
NHEK cells (Lonza CC-2501) generated by the Bernstein-Broad group for the ENCODE 
project (GEO accession GSM733701, GSM733720) and determined how many of our 
identified DMRs overlap with each set of marks. To assess the significance of overlap 
with the identified DMRs, we generated random regions from 450k probes with the same 
width and probe number as the identified regions, determined how many of these random 
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regions overlap with each histone mark and repeated this procedure 1000 times. The 
DMR list was considered to significantly overlap with a histone mark if it contained more 
overlaps than >95% of randomly generated lists. 
Affymetrix microarray expression analysis: RNA was isolated from epidermal 
samples using Trizol Reagent (Life Technologies) according to manufacturer’s 
instructions followed by clean up using the RNeasy kit (Qiagen) following the RNA 
cleanup protocol. Genome-wide gene expression analysis was done using Affymetrix 
U133 Plus 2.0 microarrays according to Affymetrix’s specifications. Data were 
normalized using fRMA as previously described [139] expression was determined using 
gene expression barcode [125]. Probes were classified as expressed if mean expression Z-
score in at least one group was >2.54. Differential expression was determined using 
limma [140]. Gene Set Enrichment Analysis was performed using the gene pattern suite 
GSEA module[141]. Significance was assessed using 1000 permutations of gene sets.   
WGBS libraries: Bisulfite sequencing libraries were constructed using the 
Illumina TruSeq DNA Library Preparation kit protocol with the following modifications. 
10 ng of unmethylated lambda DNA were added to one microgram of genomic DNA 
prior to shearing in order to monitor bisulfite conversion efficiency. After shearing, end 
repair was performed using a modified protocol to prevent introduction of non-genomic 
cytosines by using only dATP, dGTP and dTTP nucleotides with a mixtures of Klenow 
DNA polymerase, T4 DNA polymerase and T4 Polynucleotide kinase. After purification, 
samples were bisulfite converted and purified using Zymo EZ DNA Methylation Gold. 
Bisulfite converted libraries were amplified using a mixture of Uracil insensitive 
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polymerases, Denville Choice Taq and Agilent Pfu. Samples were amplified for 10 cycles 
of PCR.  
WGBS Analysis: All analyses were performed using R 3.0.1. To process 
sequencing data, we ran the BSmooth [45] bisulfite alignment pipeline (version 0.4.5-
beta) on the 100-by-100 bp HiSeq 2000 paired end sequencing reads obtained for each 
sample, using Bowtie2 version 2.0.1 [142] and the hg19 build on the human genome as 
well as the genome for lambda phage. Table 1.6 summarizes the alignment results. After 
alignment, BSmooth was used to extract read-level measurements, summarized in Table 
1.7. We filtered out measurements with mapping quality <20 or nucleotide base quality 
<10 and we removed measurements from the 5’ most 10 nucleotides of both mates. 
BSmooth was used to sort read-level measurements by genomic coordinates and compile 
a summary table. 
Next, BSmooth was used to identify large hypomethylated blocks as described in 
detail previously [28, 45, 114]. CpGs with coverage of 2 or greater in each sample group 
(O-exp, O-pro, Y-exp, Y-pro) were included in the analysis. We used the same cutoffs 
used in studies of cancer, specifically a t-statistic cutoff of -2, 2. We estimated variance 
based on the younger, sun-protected samples. Identified blocks were filtered to include 
only blocks >10kb and with a mean difference of >5%.  
Data Availability: Array and sequencing data are available in GEO under 




Figure 1.1: Hemotoxylin and eosin staining of dispase separated epidermis. 
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Figure 1.2: DNA methylation in epidermal but not dermal samples clusters by age and sun 
exposure.  
(A) In epidermis, DNA methylation segregates old vs. young individuals, and also segregates 
sun-exposed and sun-protected anatomical regions, shown by multidimensional scaling of 
pairwise distances derived from methylation levels assayed on the HumanMethylation450 
Beadchip. (B) In dermis, DNA methylation does not segregate samples by age or anatomical 
region, shown by multidimensional scaling of pairwise distances derived from methylation levels 



























































Figure 1.3: Block hypomethylation progresses from younger sun-protected to older sun-
protected to younger sun-exposed to older sun-exposed tissue.   
(A) Example of a region identified as a block comparing older sun-exposed to younger sun-
protected epidermal samples using 450k data. Top panel: Shown are methylation beta values 
(methylated signal/total signal) for “collapsed” measurements of methylation from open sea 
probes in 450k data. These are methylation averages for each 1500 bp open sea region calculated 
as part of the Minfi’s “block finder” algorithm. The points represent individual samples at each 
location, dotted lines show smoothed measurements across the region for each individual and 
solid lines represent the smoothed average for each group. The box demarcates the block 
identified using Minfi. Bottom panel: shown are smoothed methylation beta values from WGBS 
data within the regions identified in 450k analysis. Horizontal bars indicate the locations of 
hypomethylated blocks identified previously in cancer and heterochromatin LOCKs [28]. (B) 
Example of a region identified as a block comparing older, sun-exposed and younger, sun-
protected epidermal samples using 450k data, plotted as in A. (C) Heatmap showing mean block 
methylation in all blocks identified comparing O-exp and Y-pro epidermis. Samples are ordered 
by mean methylation, and blocks are ordered by mean difference in methylation between O-exp 
and Y-pro samples. Red/yellow indicate lower/higher mean methylation levels, respectively. (D) 
Relationship between block methylation and Griffiths’ photoage grade. Mean methylation within 
all blocks identified comparing O-exp and Y-pro epidermis, versus Griffiths’ photoage grade 
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Figure 1.4: The unpaired analysis is conservative relative to a paired test.  
Shown are the t-statistics calculated fro each probe comparing sun-exposed and sun-protected 
samples from older individuals using a paired t-test versus those calculated using an unpaired t-
test. 
 
Figure 1.5: Hypomethylated blocks identified in 450k data separate O-exp and Y-pro 
samples analyzed using WGBS.   
Heatmap showing mean methylation from WGBS data in regions identified as blocks comparing 
O-exp and Y-pro epidermis in 450k data. Samples and blocks are ordered by hierarchal clustering.  
























Figure 1.6: Hypomethylated blocks in O-exp samples replicated by whole genome bisulfite 
sequencing.  
(A-C) Hypomethylation is enriched in blocks. Distribution of high-frequency smoothed 
methylation values from CpGs with sufficient coverage from WGBS for (A) all CpGs, (B) CpGs 
in blocks, and (C) CpGs outside of blocks. (D) Examples of blocks identified by WGBS. Shown 




Figure 1.7: Methylation in sun exposed samples correlates with sun exposed age grade.  
Shown is mean methylation within blocks identified comparing O-exp and Y-pro epidermis for 
each sun-exposed epidermal sample versus Griffths’ photoage grade assigned to sample donor. 
(B) Methylation in photoprotected samples does not correlate with photoprotected age grade. 
Shown is mean methylation within blocks identified comparing O-exp and Y-pro epidermis for 
each sun-protected epidermal sample versus Helfrich photoprotected age grade assigned to 
sample donor. 
 
Figure 1.8: Mean block methylation does not correlate with BMI or smoking status. 
(A) Mean methylation within blocks identified comparing O-exp and Y-pro epidermis for each 
sun-exposed epidermal sample versus donor BMI. (B) Mean methylation within blocks identified 














































































































































































Figure 1.9: Differential gene expression in epidermal samples with sun exposure and aging.  
A) Volcano plot comparing significance and magnitude of differential expression for the O-exp 
vs Y-pro comparison. B) Distribution of p-values for the O-exp vs Y-pro comparison. C) Volcano 
plot comparing significance and magnitude of differential expression for the O-pro vs Y-pro 
(Intrinsic Age) comparison. D) Distribution of p-values for the O-pro vs Y-pro (Intrinsic Age) 
comparison. E) Volcano plot comparing significance and magnitude of differential expression for 
the Y-exp vs Y-pro (Exposure) comparison. F) Distribution of p-values for the Y-exp vs Y-pro 






Figure 1.10: Expression of melanocyte markers is not significantly different with aging and 
sun exposure status.  
A) Log2 expression of melanocyte marker, MITF, measured by 3 Affymetrix probes versus age 
and sun-exposure status for epidermal samples. B) Log2 expression of melanocyte marker, 



































































































Table 1.1: Donor Characteristics 
Ethnicity Biopsy Sites Griffiths Helfrichs Age BMI Method 
Caucasian left lateral eye, 
UIA (Upper 
Inner Arm) 
6 5 61 43 450K 
Caucasian left lateral eye, 
UIA 
0 0 22 20 450K 
Caucasian left lateral eye, 
UIA 
0 0 28 27 450K 
Caucasian right lateral eye, 
UIA 
2 0 34 23 450K 
Caucasian left lateral eye, 
UIA 
8 8 69 25 450K 
Caucasian right DF 
(Dorsal 
Forearm), UIA 
1 0 29 22 450K 
Caucasian left DF, UIA 7 5 70 25 450K 
Caucasian left DF, UIA 8 8 72 26 450K 
Caucasian right DF, UIA 1 1 21 27 450K 
Caucasian right DF, UIA 2 2 28 25 450k 
Caucasian left DF, UIA 3 2 30 23 450k, 
Expression 
Caucasian left DF, UIA 7 8 74 26 450k 
Caucasian left DF, UIA 2 0 30 26 450k, 
Expression 
Caucasian right DF, UIA 8 8 83 26 450k, 
Expression 
Caucasian left DF, UIA 1 1 25 19 450k, 
Expression 
Caucasian left DF, UIA 7 7 65 24 450k, 
Expression 
Caucasian left DF, UIA 7 8 >90 22 450k, 
Expression 
Caucasian right DF, UIA 8 8 84 24 450k, 
Expression 
Caucasian left DF, UIA 5 5 65 22 450k, 
Expression 
Caucasian left DF, UIA 0 0 20 30 450k, 
Expression 
Caucasian left DF, UIA 0 0 25 22 WGBS 
Caucasian left DF, UIA 0 0 23 25 WGBS 
Caucasian left DF, UIA 0 0 18 26 WGBS 
Caucasian left DF, UIA 6 6 75 34 WGBS 
Caucasian left DF, UIA 4 6 74 25 WGBS 




Table 1.2: OE-YP Blocks 






chr14 101071136 101970684 0 8.25% 7.01% 6.76% 
chr1 2565265 3315330 0 8.66% 6.72% 8.64% 
chr11 4686966 5566461 0 8.04% 9.11% 9.20% 
chr11 55110223.5 56185228 0 9.03% 8.50% 11.73% 
chr14 105974213 106444921.5 0 9.28% 7.38% 7.54% 
chr1 158223723.5 158817808 0 11.22% 10.49% 11.12% 
chr1 248042285 248685382 0 8.46% 5.44% 8.76% 
chr11 131672204 132031541 0 8.88% 3.80% 10.64% 
chr7 136563350 137139113 0 8.37% 7.85% 10.98% 
chr12 97433383 98577192 0 9.50% 6.89% 10.03% 
chr13 53595003 54943816 0 8.67% 5.66% 10.21% 
chr7 77703597 78982418 0 9.05% 6.44% 9.14% 
chr4 16504511 16883525 0 11.45% 8.06% 9.81% 
chr5 156074058 156698854 0 9.55% 7.99% 7.94% 
chr7 1553192.5 1819257 0 9.04% 5.15% 6.74% 
chr13 36110868 36738072 0 9.38% 6.60% 9.01% 
chr3 116996975 117836331 0 11.38% 12.70% 11.22% 
chr15 96715164 97345374 0 9.69% 4.37% 3.56% 
chr2 6086404 6920924 0 8.93% 7.21% 11.22% 
chr8 34182528 35417823 0 10.59% 9.46% 12.24% 
chr2 79312444 79587308 0 11.71% 11.98% 12.97% 
chr9 138289504 138619497 0 8.72% 6.14% 7.76% 
chr16 19971547 20493661 0 9.40% 6.32% 8.86% 
chr8 23830907 24507197 0 9.57% 5.73% 8.15% 
chr5 155133584 155877178 0 8.80% 7.04% 9.18% 
chr7 18043678 18832603.5 0 9.40% 3.32% 7.53% 
chr15 95847523 96538912 0 8.64% 3.21% 9.17% 
chr3 24961439 25635650 0 9.53% 12.37% 7.88% 
chr16 77797358 78024002 0 9.73% 4.96% 7.55% 
chr5 9623366 10150122.5 0 10.16% 8.08% 8.56% 
chr1 76251948 76723043 0 9.90% 7.18% 8.77% 
chr3 118144311 118792317 0 11.31% 9.02% 9.93% 
chr11 40136810 40359642 0 14.82% 14.61% 11.88% 
chr5 127744238 128150396 0 11.02% 5.40% 8.78% 
chr4 72608149 73020263 0 10.85% 6.34% 10.79% 
chr15 87410878 88053404 0 11.68% 8.60% 11.32% 
chr6 153155784 153552343.5 0 10.45% 5.83% 6.77% 
chr6 133908606 134175949 0 9.77% 7.41% 8.28% 
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chr6 133480830 133788156 0 11.91% 7.13% 9.17% 
chr3 33910459 34429403 0 10.61% 6.54% 8.54% 
chr5 174543104 174862224 0 11.63% 6.30% 7.69% 
chr6 126984891 127535312.5 0 11.74% 2.79% 11.27% 
chr2 124440055 125086435 0 11.78% 6.03% 10.15% 
chr1 159408079 159685185 0 11.85% 12.40% 10.86% 
chr10 69146234 69456351.5 0 12.37% 8.72% 9.21% 
chr8 54943820 55356479 0 11.36% 6.21% 5.55% 
chr15 60233780 60455085 0 -10.33% -5.56% 0.05% 
chr2 135290945 135625209 0 11.05% 4.71% 7.76% 
chr7 11730278 12376625 0 10.70% 7.08% 9.71% 
chr7 157845265 158155974 0.001 7.57% 4.94% 4.60% 
chr4 187664780 187869873 0.001 11.13% 4.75% 4.48% 
chr8 96694077 97249283 0.001 9.77% 2.90% 7.28% 
chr20 29844562 30126382 0.001 9.76% 4.49% 6.56% 
chr4 176339367 177163167 0.001 10.62% 4.34% 8.58% 
chr12 62404795 62685785 0.001 15.65% 7.25% 6.19% 
chr8 105508496 105962177 0.001 11.84% 7.39% 4.17% 
chr7 61968148 62198343 0.001 8.92% 7.02% 10.37% 
chr22 48792702 49080471 0.001 11.45% 8.50% 8.59% 
chr19 54947714 55459006 0.002 6.61% 5.10% 7.73% 
chr11 59836817 60553755 0.002 7.04% 7.27% 10.37% 
chr11 124120737 124487316 0.002 10.22% 9.28% 9.80% 
chr11 56264709.5 56643145 0.002 8.47% 7.59% 8.62% 
chr4 95762700.5 96761411 0.002 8.86% 4.23% 8.64% 
chr5 40905255 41418757 0.002 8.65% 9.22% 11.88% 
chr3 29623882 30140788 0.002 9.42% 2.51% 8.88% 
chr4 92879355 93443138 0.002 15.66% 10.38% 8.99% 
chr12 81077928 81349606 0.002 10.00% 7.54% 6.33% 
chr16 85873323 86431983 0.003 6.79% 5.27% 6.86% 
chr2 79823717 80557293 0.003 8.46% 6.08% 11.13% 
chr16 1093274 1331552 0.003 8.73% 8.12% 9.42% 
chr13 47316638 48046005 0.003 7.99% 6.33% 8.68% 
chr7 90149438 90682867 0.003 8.62% 2.94% 9.43% 
chr11 91536479 92150122 0.003 8.68% 8.47% 10.45% 
chr2 5201639 5749552 0.003 8.33% 7.12% 9.96% 
chr7 141674839 141999568 0.003 8.26% 7.25% 10.37% 
chr11 134479385 134911302 0.003 9.43% 5.68% 3.30% 
chr6 45709808 46112967 0.003 10.55% 5.02% 7.89% 
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chr1 247587663.5 247921656 0.003 10.09% 6.49% 9.03% 
chr6 118480809 118776527 0.003 12.38% 8.78% 9.01% 
chr12 21283725 21547892 0.004 14.62% 9.35% 11.36% 
chr1 101094117 101338750 0.004 9.42% 6.63% 7.97% 
chr5 101925501 102211822 0.004 14.12% 2.34% 3.77% 
chr11 23919652 24346161 0.004 9.32% 6.81% 12.48% 
chr8 89687477 90132979 0.004 14.35% 14.21% 13.40% 
chr13 76869358.5 77091333 0.004 13.02% 7.40% 10.61% 
chr14 47096230 47572921 0.004 13.29% 12.31% 10.62% 
chr4 18399893 19197380 0.004 12.62% 6.49% 10.21% 
chr4 70808994 71346433 0.005 8.00% 10.28% 9.66% 
chr3 139557385 140587268 0.005 8.22% 5.03% 8.08% 
chr10 31300871 31907941 0.005 8.41% 0.54% 6.34% 
chr1 237272840 238027783 0.005 7.77% 8.84% 9.93% 
chr5 33563927 33901508 0.005 9.81% 6.59% 8.68% 
chr13 107769911 108110276 0.005 9.32% 10.38% 10.90% 
chr8 56131518 56437701.5 0.005 8.50% 5.91% 6.50% 
chr3 182833979.5 183049041 0.005 10.29% 3.70% 1.13% 
chr2 2176774 2402494.5 0.005 9.86% 10.16% 8.50% 
chr12 20556313 20848553 0.005 10.69% 7.18% 10.49% 
chr8 134594669 135056370 0.006 8.30% 4.11% 6.24% 
chr7 24007534 24517414 0.006 8.16% 0.86% 6.65% 
chr4 177250214 177654753 0.006 8.73% 4.48% 9.43% 
chr5 136112615 136530712 0.006 8.93% 9.52% 6.30% 
chr3 172635656 173001443 0.006 9.97% 11.26% 11.58% 
chr12 28570321 29021552 0.006 11.20% 6.35% 3.17% 
chr16 58885137 59363443 0.006 10.12% 10.08% 11.58% 
chr6 29080188 29497165 0.007 7.57% 7.18% 10.69% 
chr11 6865733.5 7369177 0.007 7.62% 4.44% 4.19% 
chr3 115079279 115524110.5 0.007 9.01% 6.58% 7.38% 
chr6 114466051 114898257 0.007 9.14% 9.66% 5.42% 
chr13 94764647 95133339 0.007 9.21% 8.83% 6.57% 
chr22 44220872 44682494 0.007 9.59% 0.93% 3.46% 
chr7 17138805 17460742 0.007 11.96% 0.46% 1.58% 
chr5 87018149 87246732 0.007 12.79% 8.28% 12.03% 
chr3 2696551 3184210 0.008 7.90% 6.62% 8.53% 
chr7 93540134 93919388 0.008 8.66% 6.15% 9.02% 
chr3 108474544 108953233 0.008 8.58% 10.56% 9.34% 
chr3 167172692 167659189 0.008 9.16% 7.24% 5.18% 
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chr1 240450031 240723218 0.008 10.19% 8.31% 9.49% 
chr16 47733368 48157560 0.009 8.86% 7.12% 7.29% 
chr2 167115691 167395901 0.009 8.60% 6.69% 9.26% 
chr8 28984472 29316633 0.009 8.17% 1.85% 1.28% 
chr11 30488071 30771240 0.009 10.79% 3.88% 7.84% 
chr11 1043901.5 1307160 0.01 7.53% 7.56% 7.15% 
chr4 113776216 114288822 0.01 8.16% 9.19% 9.39% 
chr15 26860777 27300396 0.01 7.65% 5.70% 6.52% 
chr13 36927379 37422671 0.01 8.29% 4.81% 7.60% 
chr4 127771714 128125758 0.01 9.63% 7.32% 11.62% 
chr8 69216882 69539427 0.01 12.37% 6.39% 8.40% 
chr5 30390070 31048607 0.011 10.23% 11.58% 11.88% 
chr11 130271835 130642799 0.012 6.66% 3.61% 6.42% 
chr14 62343481 62550952.5 0.012 8.88% 7.81% 9.32% 
chr4 20006267 20529826.5 0.012 10.00% 7.18% 7.34% 
chr10 129910440.5 130268807.5 0.013 8.05% 6.17% 4.78% 
chr20 31482267 31830434 0.014 7.68% 6.75% 5.62% 
chr1 4000362.5 4275141 0.014 6.38% 6.84% 8.23% 
chr10 10099487 10631670 0.014 8.64% 9.96% 10.56% 
chr5 113512006 113806337 0.014 9.03% 7.58% 8.26% 
chr2 50623873 51074910 0.014 8.76% 10.26% 7.85% 
chr11 121593844.5 121835505 0.014 7.66% -1.99% 8.90% 
chr3 131538721 131855983 0.014 12.65% 5.81% 9.23% 
chr12 55524042 55945613 0.015 7.78% 8.59% 9.84% 
chr7 155613378 155828267 0.015 8.90% 8.27% 7.82% 
chr11 28399958 28857582 0.015 7.80% 5.29% 4.62% 
chr3 116428355.5 116835240 0.015 8.33% 8.41% 10.77% 
chr2 48920986 49271470 0.015 8.24% 8.44% 6.14% 
chr22 44963721 45330569 0.015 8.22% 3.82% 5.82% 
chr13 67676107 68261695 0.015 10.41% 7.66% 10.62% 
chr8 35501934 35762637 0.015 11.87% 8.09% 12.91% 
chr3 188618380 188868983 0.015 9.33% 0.42% 1.18% 
chr3 161235909 161577612 0.015 9.55% 8.01% 10.49% 
chr16 77098093 77574072 0.016 7.89% 4.66% 8.54% 
chr1 157509149 157938690 0.017 7.86% 10.59% 9.46% 
chr5 166419955 166938213 0.017 8.62% 5.69% 8.31% 
chr14 79760047 79968686 0.017 8.56% 6.52% 3.73% 
chr10 52566320 53071348 0.018 7.68% 4.66% 6.54% 
chr1 239287722 240029733 0.018 7.73% 4.59% 11.25% 
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chr1 77477593 77879031 0.018 8.57% 7.24% 4.73% 
chr6 72178744 72455356 0.018 11.25% 3.19% 8.47% 
chr5 88081844 88432540 0.018 10.49% 5.96% 4.02% 
chr5 156900363 157107153 0.019 8.43% 1.06% 4.64% 
chr3 19026539 19521725 0.02 7.98% 3.77% 11.03% 
chr8 105244257 105453719 0.02 9.18% 3.90% 6.49% 
chr2 143987421 144303521 0.02 9.62% 0.79% 9.27% 
chr2 11024896 11245460.5 0.021 8.94% 2.01% 4.14% 
chr12 11508049 11767243 0.021 8.69% 5.00% 6.55% 
chr8 131705773 132404163 0.021 9.48% 6.88% 10.38% 
chr8 15873055 16240240 0.021 10.25% 9.20% 10.47% 
chr8 40319233 40811496 0.022 7.22% 8.26% 6.21% 
chr12 15501337 15983280 0.022 6.80% 3.35% 4.56% 
chr7 119831208 120689323 0.022 7.60% 4.69% 8.30% 
chr7 43177046 43435880 0.022 8.14% 6.16% 4.04% 
chr3 148360785 148592849 0.022 8.30% 9.82% 6.08% 
chr10 44426803 44910229 0.023 7.20% 7.65% 5.45% 
chr16 71008391 71221950 0.023 7.88% 2.26% 7.89% 
chr4 173470589 173905761 0.023 10.20% 10.16% 10.31% 
chr14 19553612 19829406 0.023 8.95% 4.92% 7.76% 
chr2 225965431 226439867 0.023 11.55% 7.47% 6.25% 
chr2 1507763 1732313 0.024 7.09% 1.98% 6.17% 
chr1 198466913 198850158 0.024 7.53% 7.77% 6.94% 
chr3 135631071 135957815 0.024 7.95% 3.06% 0.94% 
chr6 70762024 71136165 0.024 10.22% 7.62% 6.83% 
chr17 77173076 77702964 0.025 5.38% 4.39% 7.11% 
chr8 108238734 108511437 0.026 7.97% 5.40% 8.38% 
chrX 140673351 140997122 0.026 7.26% 9.20% 5.10% 
chr7 3041094.5 3313269 0.027 7.08% 3.63% 4.50% 
chr19 51883242 52114809 0.027 7.31% 4.58% 4.43% 
chr5 146812118 147052436 0.027 7.03% 4.60% 4.07% 
chr13 103702677 104168550 0.027 8.65% 7.31% 7.70% 
chr17 3056402 3379425 0.028 7.06% 5.31% 5.84% 
chr2 100498600 100926650 0.031 6.69% 6.10% 7.17% 
chr6 134609828 134963096 0.031 7.26% 8.08% 1.14% 
chr1 107224529 107886561 0.031 8.80% 4.60% 4.03% 
chr7 121895636 122636635 0.032 6.98% 2.36% 6.85% 
chr6 24704389 24950870 0.032 7.57% 4.10% 3.88% 
chr2 236139863 236417406 0.032 7.06% 1.79% 4.28% 
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chr3 11939930.5 12269362 0.032 7.83% 4.01% 5.25% 
chr4 69207281 69681824 0.032 8.33% 5.70% 8.67% 
chr13 98507990 98968161 0.035 6.00% 3.68% 6.40% 
chr6 153938192 154429895 0.035 9.57% 4.25% 11.65% 
chr1 196746875 197037618 0.035 8.94% 7.14% 7.93% 
chrX 118750273 119030658 0.035 5.27% 0.40% 0.93% 
chr16 86917536 87119252 0.036 6.02% 2.98% 6.07% 
chr11 89232216 89735737 0.037 7.31% 7.45% 10.57% 
chr13 108434882.5 108953856.5 0.037 7.45% 1.77% 9.28% 
chr8 122598941 122863171 0.037 9.13% -0.05% 3.61% 
chr1 238341559 238811442 0.037 12.33% 2.88% 6.14% 
chr11 19598794 19860035 0.038 7.69% 5.35% 3.12% 
chr4 5865654 6196445 0.038 6.58% 3.44% 6.05% 
chr2 179544947 179974586 0.039 6.54% 7.82% 6.98% 
chr15 59903988.5 60110153 0.039 9.61% 2.85% 2.94% 
chr7 37873301.5 38269241 0.04 7.26% 3.62% 9.01% 
chr3 173574358 174048079 0.04 8.23% 10.16% 8.51% 
chr17 54230707.5 54509207 0.04 9.23% 3.29% 9.00% 
chr13 43119835 43395572 0.041 7.65% 1.64% 8.49% 
chr8 76147299 76477653 0.041 10.14% 10.07% 9.00% 
chr5 169482268 169780607.5 0.042 7.41% 8.80% 8.32% 
chr5 82109937 82395650 0.043 7.12% 4.55% 4.73% 
chr12 72071095 72477363 0.044 6.96% 4.43% 4.71% 
chr5 64372500 64666244 0.044 7.38% 4.70% 8.58% 
chr13 112800009.5 113049747 0.045 5.77% 3.73% 6.64% 
chr3 16738417 17082105 0.046 6.66% 6.24% 8.16% 
chr17 76704594 76936927 0.049 5.95% 0.32% 2.84% 
chr15 38641673 39145977 0.049 6.25% 3.80% 3.24% 
chr14 20247808 20692622 0.049 7.20% 7.17% 8.82% 




Table 1.3: YE-YP Blocks 
Chr Start End FWER Width (bp) 
chr15 96797664 97250927 0 453263 
chr5 101925501 102193800 0 268299 
chr6 126984891 127484100 0.001 499209 
chr6 134570471 134963096 0.002 392625 
chr6 1836850 2134144 0.002 297294 
chr13 100376969 100578708 0.005 201739 
chr2 177510485 177872615 0.016 362130 
chr15 47618795 47967175 0.019 348380 
chr5 166419955 166620727 0.022 200772 
chr7 17138805 17424006 0.037 285201 
chr1 50907107 51168010 0.047 260903 





Table 1.4:OE-YE Blocks 
Chr Start End FWER Width 
chr11 4791012 5474774.5 0 683762.5 
chr11 55541269 56143818 0 602549 
chr1 158223723.5 158799979.5 0 576256 
chr14 101302507 101595517.5 0.001 293010.5 
chr1 2615690 3143745 0.001 528055 
chr3 164621774 164915196 0.001 293422 
chr14 106053344 106410681 0.002 357337 
chr13 94461196 95022023 0.003 560827 
chr2 79312444 79515161.5 0.003 202717.5 
chr5 155379667 155956646 0.004 576979 
chr5 156110742 156642345 0.005 531603 
chr16 19971547 20493661 0.005 522114 
chr1 248307095 248637451 0.005 330356 
chr11 40136810 40359642 0.005 222832 
chr4 16532808 16795757 0.006 262949 
chr7 136563350 136953057 0.008 389707 
chr9 138362412.5 138586311 0.01 223898.5 
chr3 25101907 25493807 0.01 391900 
chr6 29232436 29443423 0.016 210987 
chr7 61968148 62198343 0.016 230195 
chr11 124172447 124413717 0.017 241270 
chr8 34843233 35297622 0.018 454389 
chr5 127744238 128034864 0.021 290626 
chr11 91717555 92116826 0.023 399271 
chr12 97924358 98178057 0.023 253699 
chr3 116996975 117329281 0.024 332306 
chr8 89687477 90132979 0.025 445502 
chr7 93697091 93984889 0.031 287798 
chr1 157567720 157811604 0.031 243884 
chr15 87436107 87892167 0.037 456060 
chr6 133529701 133757084 0.048 227383 
chr6 153224221 153552343.5 0.05 328122.5 





Table 1.5: Block Finding Summary 










O-exp vs Y-pro 
(Sun + Age) 224 99 Mb 9.20% 670 Mb 9.00% 
Y-exp vs Y-pro 
(Sun/Site) 12 3.8 Mb 9.30% 0.9 Mb 7.30% 
O-exp vs O-pro 239 100 Mb 8.60% 1.5 Mb 7.50% 
O-pro vs Y-pro 
(Age) 0 - - 6.2 Mb 7.10% 
O-exp vs Y-exp  33 12.7 Mb 10.00% 8.5 Mb 8.00% 
Dermis Number Total Width Mean Difference     
O-exp vs Y-pro 0 - - NA NA 
Y-exp vs Y-pro 0 - - NA NA 
O-pro vs Y-pro 0 - - NA NA 





Table 1.6: WGBS Alignment Summary 
Sample # paired-ends 
reads sequenced 
# ends sequenced 
(reads x2) 
# ends aligned alignment rate 
Older, 
Exposed 1 


















































Table 1.7: WGBS BSmooth Summary 
Sample Covered 
CpGs 






24609491 87.21% 5.68 21418192 87.03% 
Older, 
Exposed 2 
24869681 88.14% 5.83 21430311 86.17% 
Older, 
Exposed 3 
24865651 88.12% 5.71 21510892 86.51% 
Older, 
Protected 1 
24945707 88.41% 6.48 21933497 87.92% 
Older, 
Protected 2 
24387124 86.43% 4.97 21084564 86.46% 
Older, 
Protected 3 
25055896 88.80% 5.96 21893277 87.38% 
Younger, 
Protected 3 
24853692 88.08% 6.07 21846635 87.90% 
Younger, 
Exposed 1 
24948670 88.42% 6.12 21862022 87.63% 
Younger, 
Exposed 2 
25047251 88.77% 6.55 21967490 87.70% 
Younger, 
Exposed 3 
24803372 87.90% 5.71 21719843 87.57% 
Younger, 
Protected 1 
24787671 87.85% 6.44 21810045 87.99% 
Younger, 
Protected 2 




Table 1.8:GSEA Results 
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CHEMNITZ_RESPONS 118 -0.51 -2.12 0 3.19E- 0.034 
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Table 1.9: OE-YP Small DMRs 
Chr Start End FWER 
Mean Difference 
in Methylation-
OE vs YP Samples 
chr7 27196759 27198896 0 37.68% 
chr5 134362967 134364717 0 37.19% 
chr16 85320035 85320882 0 -41.31% 
chr17 4648566 4649262 0 43.14% 
chr7 27199726 27199956 0.001 52.39% 
chr7 27191097 27192656 0.003 33.42% 
chr7 134832221 134833166 0.003 -34.00% 
chr4 54959419 54960259 0.003 34.65% 
chr10 3158688 3159145 0.003 49.57% 
chr13 25085301 25085669 0.003 -51.81% 
chr7 27183861 27185512 0.004 31.25% 
chr4 1352787 1353919 0.004 -34.19% 
chr12 2944163 2944493 0.004 34.29% 
chr15 102009795 102010195 0.004 -34.01% 
chr1 243584668 243584861 0.004 -50.62% 
chr4 187762256 187762379 0.005 -49.33% 
chr6 32819858 32820249 0.006 -32.92% 
chr15 37389384 37390326 0.006 33.37% 
chr8 141577061 141577526 0.006 33.61% 
chr6 161860203 161860561 0.006 -47.09% 
chr7 2076633 2076633 0.007 -63.63% 
chr2 172951828 172953925 0.01 30.58% 
chr2 127978490 127978579 0.011 -46.61% 
chr7 2654420 2654420 0.011 -61.49% 
chr6 33288561 33289208 0.013 -26.61% 
chr22 51016501 51017019 0.013 30.94% 
chr11 31818791 31819678 0.013 31.58% 
chr7 862427 862831 0.013 -31.97% 
chr17 80255419 80255510 0.013 -45.39% 
chr5 80529067 80529340 0.014 31.37% 
chr8 116679763 116680127 0.014 -40.33% 
chr17 8129997 8130356 0.014 44.70% 
chr8 74903761 74903801 0.014 -44.52% 
chr7 19149989 19150174 0.014 -44.46% 
chr17 73805953 73805997 0.015 -44.31% 
chr12 115134201 115135333 0.016 -25.75% 
chr7 27154562 27155358 0.016 29.38% 
chr19 16830613 16830859 0.016 -38.47% 
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Chr Start End FWER 
Mean Difference 
in Methylation-
OE vs YP Samples 
chr2 223917577 223918000 0.016 39.13% 
chr5 137803102 137803362 0.016 -38.93% 
chr3 160121821 160122503 0.016 -38.76% 
chr6 121767874 121767882 0.017 -44.15% 
chr17 40715222 40715281 0.019 -38.09% 
chr15 63220652 63220652 0.019 -56.50% 
chr12 115103960 115105710 0.02 -28.64% 
chr7 157866922 157867812 0.02 -30.15% 
chr19 49340489 49340765 0.02 38.16% 
chr15 31774773 31775049 0.02 -42.97% 
chr7 130626376 130626559 0.021 -42.53% 
chr8 12668973 12669347 0.021 -41.56% 
chr1 94560697 94560851 0.022 -43.18% 
chr6 31698218 31698226 0.025 40.98% 
chr16 66612955 66613355 0.028 28.50% 
chr11 31827084 31828040 0.028 28.84% 
chr11 31820441 31822526 0.029 26.96% 
chr2 135594780 135594780 0.029 -54.29% 
chr11 268923 269468 0.03 -35.98% 
chr2 172945144 172947075 0.031 28.24% 
chr17 76220608 76220955 0.031 29.18% 
chr11 65546988 65547172 0.031 -36.30% 
chr2 172956823 172958358 0.032 28.65% 
chr6 2891973 2892152 0.032 -35.76% 
chr17 80194576 80195737 0.032 -29.04% 
chr11 31825756 31825969 0.033 35.84% 
chr12 133156510 133156565 0.033 39.62% 
chr12 115129011 115129801 0.034 39.39% 
chr6 169051407 169051431 0.035 39.13% 
chr3 188697399 188697399 0.035 -53.60% 
chr2 100279893 100279893 0.035 -53.50% 
chr11 70001754 70002283 0.036 -34.74% 
chr10 6117324 6117324 0.036 -53.27% 
chr7 140227195 140227335 0.037 -38.47% 
chr3 187086147 187086530 0.038 -34.96% 
chr2 54086854 54087517 0.039 26.19% 
chr7 101723207 101723947 0.039 -27.98% 
chr16 1583810 1584118 0.039 27.92% 
chr7 110838461 110838461 0.04 -52.65% 
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Chr Start End FWER 
Mean Difference 
in Methylation-
OE vs YP Samples 
chr7 19152017 19152335 0.043 -34.44% 
chr6 28921103 28922226 0.044 25.85% 
chr5 54518667 54519307 0.044 27.57% 
chr7 155252201 155252944 0.045 33.66% 
chr6 29943188 29943677 0.047 25.80% 
chr15 37394754 37395171 0.049 33.36% 
chr7 157179773 157179830 0.05 -37.23% 
chr17 77134303 77134303 0.05 -51.66% 
chr19 10370550 10370550 0.05 -51.61% 
chr8 69879951 69879951 0.05 -51.50% 
chr12 2046045 2046230 0.052 -39.36% 
chr14 101459547 101459591 0.052 -39.25% 
chr2 223916502 223916861 0.053 26.98% 
chr15 81666393 81666671 0.053 -37.15% 
chr10 8090846 8090924 0.053 -39.12% 
chr6 118672731 118672731 0.053 -51.41% 
chr16 1231407 1232363 0.054 -26.88% 
chr14 104184551 104184575 0.054 39.04% 
chr11 65816463 65816819 0.055 26.85% 
chr11 31845148 31845639 0.055 33.63% 
chr4 54554571 54554571 0.055 -51.02% 
chr14 24640947 24642219 0.056 24.12% 
chr7 155255122 155255791 0.056 32.90% 
chr15 32933704 32934185 0.056 26.77% 
chr6 32805398 32805692 0.056 -26.74% 
chr1 245812674 245812674 0.057 50.75% 
chr6 31650735 31651158 0.059 22.99% 
chr7 27140797 27142100 0.059 26.13% 
chr11 31824973 31825226 0.059 33.53% 
chr11 19372012 19372014 0.059 38.31% 
chr7 3186766 3186788 0.059 -38.31% 
chr12 115137528 115138766 0.06 -26.09% 
chr16 15595889 15596215 0.062 -26.51% 
chr10 820767 821718 0.062 -31.75% 
chr1 233085132 233085383 0.062 -36.10% 
chr11 31840628 31841980 0.063 25.85% 
chr16 89734986 89735184 0.064 -37.98% 
chr1 207224549 207225647 0.065 -25.86% 
chr13 33780078 33780362 0.066 31.37% 
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Chr Start End FWER 
Mean Difference 
in Methylation-
OE vs YP Samples 
chr3 124860616 124860871 0.066 35.97% 
chr5 101925501 101925501 0.067 -50.19% 
chr11 334298 334833 0.068 32.73% 
chr22 44568387 44568812 0.069 -25.09% 
chr6 35479628 35479910 0.07 35.83% 
chr14 52241096 52241174 0.07 -37.91% 
chr7 156336589 156337209 0.071 26.01% 
chr16 3998752 3998816 0.072 35.71% 
chr1 29587088 29587255 0.072 35.66% 
chr12 12224246 12224457 0.072 -37.76% 
chr1 88421825 88421825 0.072 -49.82% 
chr21 44486205 44486452 0.073 -32.25% 
chr3 194407860 194408965 0.075 25.08% 
chr22 46457384 46457998 0.076 -35.39% 
chr2 131720820 131721768 0.079 30.57% 
chr12 97300410 97300429 0.079 -35.22% 
chr7 155262490 155263349 0.079 35.21% 
chr6 52171973 52172083 0.079 35.19% 
chr11 70303464 70303534 0.079 -37.42% 
chr16 88458618 88458669 0.079 -37.37% 
chr3 147126703 147127012 0.08 25.72% 
chr2 74875227 74875548 0.081 24.49% 
chr1 228248013 228248785 0.081 31.80% 
chr4 141207794 141207852 0.081 -35.12% 
chr16 1145964 1146545 0.082 -25.55% 
chr21 45581541 45581710 0.083 -35.02% 
chr5 110427072 110427112 0.083 -37.23% 
chr4 26865310 26865310 0.084 -48.89% 
chr22 46455670 46455670 0.084 -48.83% 
chr21 46378243 46379089 0.086 30.27% 
chr11 31824262 31824327 0.086 37.14% 
chr1 68084465 68084465 0.086 -48.61% 
chr12 11709115 11709115 0.087 -48.54% 
chr5 155956646 155956646 0.087 48.51% 
chr14 106187192 106187192 0.087 -48.50% 
chr12 72875216 72875216 0.087 48.49% 
chr2 119602212 119603489 0.088 22.85% 
chr8 58055024 58056113 0.088 25.29% 
chr12 115131223 115132015 0.088 25.27% 
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Chr Start End FWER 
Mean Difference 
in Methylation-
OE vs YP Samples 
chr16 15613108 15613108 0.088 48.46% 
chr16 75148330 75149501 0.091 -25.10% 
chr7 5342326 5343176 0.091 -25.10% 
chr7 157475548 157475737 0.091 34.64% 
chr6 45784526 45784526 0.093 -48.20% 
chr1 9527173 9527208 0.094 36.93% 
chr13 102104707 102105440 0.097 -23.95% 
chr9 139715701 139716215 0.097 34.43% 
chr16 1069760 1070137 0.099 -36.79% 
chr15 62853598 62853598 0.099 47.98% 





Table 1.10: Small DMR summary 
Epidermis Hyper Hypo 
O-exp vs Y-pro (Sun + 
Age) 90 76 
Y-exp vs Y-pro (Sun/Site) 20 10 
O-exp vs O-pro 55 11 
O-pro vs Y-pro (Age) 1 1 
O-exp vs Y-exp  1 13 
Dermis Hyper Hypo 
O-exp vs Y-pro 6 3 
Y-exp vs Y-pro 2 7 
O-exp vs O-pro 2 4 
O-pro vs Y-pro 1 0 














Human aging is the greatest risk factor for disease and morbidity, however the 
molecular basis remains poorly understood[46]. Aging is associated with functional 
decline and loss of homeostasis across multiple organ systems, which arises due to 
altered or reduced function of progenitor and somatic cells. Within the immune systems 
this process has been well characterized: aging is associated with increased activation of 
basal inflammatory pathways, but decreased ability to respond to new infections. This is 
attributed to both altered differentiation capacity of hematopoietic progenitor cells [77] 
and altered function of differentiated cells [79]. Because these changes occur primarily 
independently of changes to the genomic sequence and are variable among individuals, 
there has been significant interest in investigating how epigenetic modifications may 
mediate these changes. 
DNA methylation is the most commonly studied epigenetic modification and 
plays an important role in cell identity.  This modification is most frequently found in the 
context of CpG dinucleotides, where it can be placed by three methyltransferase 
enzymes: DNMT1, the maintenance methyltransferase that re-establishes the methylation 
pattern following DNA replication, and DNMT3a and DNMT3b, which function in de 
novo methylation [6].  The presence of DNA methylation in gene promoters and 
enhancers is inversely correlated with gene expression, likely due to alterations of local 
DNA structure and prevention of transcription factor binding [143]. By contrast, DNA 
methylation within gene bodies is linked to active transcription and regulation of splicing 
[144].  Maintenance of the methylome is essential for progenitor cell function, and de 
novo methylation is required for differentiation in some systems [34, 37]. 
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In addition to local, gene specific changes in methylation, large scale loss of 
methylation has been observed with cancer and EBV-immortalization [28, 31, 145].  
These changes are detectable at a global level and involve loss of methylation across 
large, gene-poor regions of the genome, termed “hypomethylated blocks”. The 
hypomethylated blocks overlap strongly with heterochromatic, lamina-associated 
domains. Intriguingly, similar large-scale hypomethylation in gene poor regions is 
observed in cells approaching replicative senescence [95]. In this work, loss of 
methylation was observed to occur preferentially in late-replicating regions, attributed to 
mislocalization of DNMT1 in late passage cells.  
 Both small and large-scale DNA methylation changes associated with aging have 
been reported in peripheral blood, however the true nature of cell intrinsic methylation 
changes with age remains unclear.  An early study using the Illumina 
HumanMethylation27 Beadchip (27k) array, a promoter-biased array, showed common 
regions of differential methylation with age in CD4+ lymphocytes and CD14+ monocytes. 
In this study, age associated hypermethylation occurred preferentially in regions 
identified as bivalent in embryonic stem cells [85], however this study was limited by the 
low coverage and bias of early array technology.  The release of the more genome scale 
Illumina HumanMethylation Beadchip450 (450k) array has facilitated more thorough 
observations: work by Hannum et al. analyzing a large cohort of peripheral blood 
samples proposed an “epigenetic clock” from which chronological age can be predicted 
based on methylation at 71 sites measured by 450k array[102]. Horvath refined this 
approach, identifying a model using 353 CpGs which is used to calculate a “methylation 
age” that correlates strongly with chronological age across a large variety of tissues and 
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cell types[89].  A recent work by Yuan et al. used the 450k array data to identify large-
scale/block level hypomethylation with age in peripheral blood [146].   
 The observations of these studies are limited by the reliance on data from 
peripheral blood, which consists of multiple cell types, each of which has a distinct 
methylome. As individuals age, the relative proportion of cells within peripheral blood 
shifts, confounding analysis of methylation data [103]. While it is possible to account 
somewhat for these changes using linear regression [146], this correction relies on the 
assumption that there are no cell type specific age related changes with age. Analysis of 
purified blood cells has been very limited: sorted CD4+ cells from one newborn and one 
centenarian examined by Heyn et al. using whole genome bisulfite sequencing (WGBS) 
showed large scale hypomethylation with age reminiscent of the hypomethylated blocks, 
however the generalizability of this result is limited by the use of only one cell type and 
single donors in each age group[94]. Another recent analysis of 450k array data from 
CD14+ monocytes and CD4+ lymphocytes from older donors indicates very distinct 
methylation changes in these cell types with age but focuses on donors over 50 years of 
age and is reliant on the coverage of the 450k array[98]. 
 In this work, we characterize cell type specific methylation age related 
methylation changes in CD14+ monocyte, CD4+ T lymphocytes and naïve CD4+ T 
lymphocytes isolated from donors ranging from 18 to 97 years of age.  We use whole 
genome bisulfite sequencing in a discovery set of 3 younger and 3 older Caucasian 
women to avoid the biases of array based analysis and identify highly distinct patterns for 
each cell type. We validated these results using the 450k array on a larger donor set. 
Intriguingly, we observe that these changes occur in cell type specific enhancer regions 
 79 
and, in naïve CD4+ cells, are enriched for binding sites for a regulatory factor involved in 
aging.  
Results 
Global hypomethylation with aging is cell type specific  
In order to identify cell type specific methylation change with age, we collected 
peripheral blood from 43 healthy donors ranging from 18 to 97 years old (demographic 
information detailed in Table 2.1).  From each individual, we isolated peripheral blood 
mononuclear cells (PBMCs) and used magnetic beads to isolate three types of blood cells, 
CD4+ T-lymphocytes, naïve CD4+ T-lymphocytes and CD14+ monocytes.  Analysis of 
sorted cells using flow cytometry post-sorting indicated high purity—97% for CD4+ cells, 
85% of naïve CD4+ cells, 95% for CD14+ cells (Figure 2.1). 
In order to gain unbiased genome wide information about DNA methylation in 
these samples, we performed whole genome bisulfite sequencing (WGBS) on CD4+ and 
CD14+ cells from 3 of the youngest (<30 years) and 3 of the oldest donors (>80 years). 
To control for sex and race in this initial set, we selected only Caucasian female donors 
for the WGBS analysis (donors indicated in Table 2.1).  We generated sequencing data to 
a depth of 5.1-6.0X and analyzed it using the BSmooth algorithm, which was designed 
for analyzing low-coverage WGBS data and has been demonstrated to accurately 
estimate methylation levels at single-base pair resolution by borrowing information from 
nearby CpGs [45]. After filtering reads with low quality measures, we obtained 
measurements for an average of 25,145591 CpGs per sample (average of 89% coverage).  
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Bisulfite conversion was assessed using spiked in lambda phage and ranged from 99.69-
99.74% (Details in Methods, Tables 2.2). 
To examine the potential for global methylation change with age, we began by 
looking at mean methylation in both cell types analyzed. Surprisingly, when considering 
all CpGs with coverage of 2 or more in each sample group, we observed a significant 
drop in mean methylation with age in CD4+ cells (mean of 81.7% methylation in the 
younger donors, 77.9% in older donors), but no change in global methylation with age in 
CD14+ cells (mean methylation of 81.5% in younger donors, 81.6% in older donors) 
(Figure 2.2A and 2.2B).  
In previous studies of colon cancer, EBV transformation and cellular senescence, 
mean hypomethylation is explained by loss of mean methylation across large regions of 
low CpG density, overlapping with heterochromatic and lamina-associated domains [28, 
31, 95]. To determine if such large regions of altered methylation are present in our 
dataset, we applied BSmooth’s region finding algorithm to data smoothed over large (20 
kbp) windows.  Applying this method to the CD4+ cell data using the same cutoffs used 
to define blocks in EBV and colon cancer, we identified hypomethylated blocks spanning 
over 622 Mbp, with an average of 7.73% difference in methylation (example block 
region shown in Fig 2.2C.) We observed a strong overlap between the detected age 
hypomethylated blocks and the previously reported colon cancer hypomethylated blocks 
(OR=7.6).  Consistent with this similarity, we also observed a significant overlap 
between the blocks hypomethylated with age and lamina associated domains previously 
mapped in fibroblasts (OR=3.3) [29] as well as H3K9me2 heterochromatic “LOCKS” 
mapped in fibroblasts (OR= 4.0) [28]. 
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It has been previously reported that the proportion of naïve cells within the CD4+ T 
cell population declines with aging [147]. To determine impact this subpopulation has on 
the observed methylation changes, we examined methylation in the naïve CD4+ cells that 
were isolated from each donor.  We observed higher mean methylation within the naïve 
CD4+ subset compared to the total CD4+ set for both young and old individuals. 
However, the regions identified as age-hypomethylated blocks within the CD4+ data are 
consistently hypomethylated with age in the naïve CD4+ subset (Fig 2.2D), indicating 
that the change in naïve CD4+ cell proportion alone cannot explain the observed 
methylation changes. 
By contrast, when the same algorithm was applied to the CD14+ cell data, only 24 
potential blocks, spanning 0.57 Mbp were identified. These blocks are both hypo and 
hyper methylated with age, consistent with the absence of mean methylation changes. 
Thus, while the widespread hypomethylation with age observed in CD4+ T-lymphocytes 
is consistent with previously reported loss of methylation in aging and occurs within 
regions that lose methylation in colon cancer, this change is cell type specific and not 
observed in all peripheral blood cell types. 
Age-related differential methylation occurs in cell type specific regulatory regions 
 We next applied BSmooth’s region finding algorithm to sequencing data 
smoothed over a smaller, 2 kb, window in order to identify specific small regions of 
larger magnitude differential methylation (DMRs).  We used the cutoffs applied to 
identify regions differentially methylated in colon cancer. We identified 1487 regions 
differentially methylated with age in the CD4+ cells (example in Figure 2.3A). Distinct 
from the widespread hypomethylation, the majority of identified small DMRs (1012) are 
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hypermethylated with age. This pattern is similar to changes identified in cancer studies: 
widespread hypomethylation with focal hypermethylation[145].  A similar pattern was 
observed within the naïve CD4+ subset: 3645 DMRs were identified, 2150 of which are 
hypermethylated with age (example in Figure 2.3B). The larger number of regions 
identified may be due to the increased purity of the cell population, reducing noise. By 
contrast, for CD14+ cells, 934 DMRs were identified, the majority of which (762) are 
hypomethylated with age (example in Figure 2.3C), again indicating a distinct 
mechanism of epigenetic change in CD14+ cells with age. The results of age-DMR 
finding from all cell types are summarized in Table 2.3. 
 While within each cell type a large number of regions is identified as age-DMRs, 
only 5 of the hypomethylated age-DMRs were identified as hypomethylated in all cell 
types, and only 10 of the hypermethylated age-DMRs were identified as hypermethylated 
in all cell types (example in Figure 2.3E).  It is possible that more common age-DMRs 
are present but are not of sufficient magnitude in all cell types to be detected using the 
relatively strict cutoffs used.  Several of the genes nearest these DMRs are intriguing: one 
common age hypermethylated DMR is nearest to MIR30D, a microRNA involved in 
regulation of p53 expression [148], another, PIK3C2A, is involved in insulin signaling 
and activation of mTORC1 [149]. A complete list of common age DMRs is provided in 
Table 2.4. 
 Previous studies have reported overlap of hypermethylated aging related DMRs 
with both polycomb targets and hypomethylated aging DMRs with enhancers marked by 
H3K4me1[88].  To determine how the identified cell type specific DMRs relate to these 
marks, we took advantage of ChIP-seq data from CD14+ and naïve CD4+ cells obtained 
 83 
as part of the Roadmap epigenome project[150]. For each cell type, we calculated the 
odds ratio for overlap between hypo and hyper methylated DMRs and ChIP-seq peaks for 
H3K27me3, H3K4me3 and H3K4me1. We also examined the overlap between each cell 
type’s age-DMRs and ChIP-seq peaks mapped in the other cell type (Figure 2.4A and 
2.4B).  For both naïve CD4 cells and CD14 cells, we observed the strongest overlap 
between hypomethylated DMRs and H3K4me1 peaks mapped in the same cell type (OR= 
10.3 and 7.2).  The overlap between hypomethyated Age DMRs and H3K4me1 peaks 
mapped in the other cell type was much weaker (OR= 4.5 and 1.4), indicating that the 
overlap between hypomethylated age-DMRs and H3K4me1 has a high degree of cell type 
specificity.   
 Intriguingly, hypermethylated age-DMRs had a distinct pattern.  In contrast to 
previous work examining only CpGs covered by the 27k array, we detect only a modest 
overlap between hypermethylated age-DMRs and H3K27me3 (OR=1.1 for naïve CD4+ 
and 2.7 for CD14+).  We observe a stronger overlap between hypermethylated age-
DMRs and H3K4me1, but not with the same cell type specificity as observed for 
hypomethylated DMRS: naïve CD4 hypermethylated age-DMRs have a similar degree of 
overlap with H3K4me1 mapped in naïve CD4 cells (OR=8.3) and in CD14 cells 
(OR=7.7), while CD14+ hypermethylated age-DMRs have a stronger overlap with 
H3K4me1 mapped in naïve CD4 cells (OR=5.9) than in CD14 cells (2.9), indicating age 
related hypermethylation may preferentially occur in putative enhancers not specific to 
the cell type.  
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Hypomethylated naïve CD4+ age-DMRs enriched for functional motifs 
Given the observed overlap between age-DMRs and enhancers, we sought to 
identify transcription factors that may differentially bind to the identified regions.  We 
used Haystack, an algorithm that looks for enrichment of known transcription factor 
binding sites in a set of genomic regions[151]. We separately analyzed hyper and 
hypomethylated DMRs from each of the three cell types sequenced (CD4+, naïve CD4+ 
and CD14+) against a background of all other DMRs identified to determine what 
distinguishes a region hypo or hypermethylated with age for a specific cell type.   
The most enriched binding motif was identified as enriched within regions 
hypomethylated with age in naïve CD4+ cells. This motif corresponds to the binding 
sequence for the B-ATF::JUN complex (Fig 2.4C) and has a center enrichment of 4.35 
within the identified regions (Fig 2.4D).  This motif is found in 17% (265) of the 
hypomethylated naïve CD4+ age-DMRs. This finding is intriguing as B-ATF is activated 
downstream of IL-6, levels of which have been observed to increase with aging [152] and 
was seen to significantly increase with chronological age in serum samples collected 
from our donors (p-value<0.001 ,Fig 2.5A). B-ATF controls Th17 differentiation from 
naïve CD4 T-cells [153] and the levels of Th17 cells have been observed to change with 
aging [154]. We see no significant difference in IL-17, a cytokine produced exclusively 
by Th17 cells in serum from our donors (Fig 2.5B), however the basal levels are very low 
and age associated changes in IL-17 are seen only after stimulation[154].  
Validation of cell type specific aging changes using the 450k array 
  Having observed cell type specific methylation changes related to aging in a 
small set of Caucasian women using whole genome bisulfite sequencing, we sought to 
 85 
determine whether these changes are present in the larger, mixed race and mixed sex 
population.  To do this, we analyzed genome wide methylation in CD4+, CD14+, naïve 
CD4+ and peripheral blood mononuclear cells (PBMCs) from all individuals sampled (43 
donors, ranging from 18 years to 97 years, information in Table 2.1) using the Illumina 
Infinium HumanMethylation450 (450k) array.   
We first examined CpGs covered by the 450k array that are located within the 
regions identified as differentially methylated from whole genome bisulfite sequencing.  
When we considered CpGs within the regions identified as age related hypomethylated 
“blocks” in CD4+ cells in WGBS, we observed a significant decrease in methylation in 
CD4+ samples from donors older than 80 as compared to CD4+ samples from donors 18-
34 years of age (two sample t-test, p< 2.2 x 10-16) (Figure 2.6A).  When we considered 
the small DMRs identified by WGBS, we were limited by the low coverage of the array 
within these regions, which are primarily far from gene promoters, so we were able to 
directly examine only a subset of DMRs.  Among the 71 identified WGBS age-DMRs 
which overlap 3 or more probes on the 450k array (20 CD4+ age-DMRS, 47 nCD4+ age-
DMRs, 4 CD14+ age-DMRs), 66 showed the same direction of differential methylation 
comparing samples from the youngest (18-34 years) and oldest (80+ donors) on the 450k 
array, 56 with a p-value <0.1 (Fig 2.6B).  
 We applied the “methylation age” model developed by Horvath[89] to determine 
how the model applies to sorted cell populations.  When we compared the calculated 
methylation age to the chronological age, we observed a very strong correlation between 
methylation age and chronological age for all cell types (R2’s from 0.90 to 0.94). Notably, 
for all individuals, the methylation age for CD4+ cells is lower than the methylation age 
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of CD14+ cells and PBMCs, indicating cell type specificity in relationship between age 
and methylation even in this limited set of 353 cytosines (Figure 2.7A).   
 We next identified the probes most significantly differentially methylated with 
age. We fit a linear model for methylation versus age adjusting for sex and race, 
separately for each cell type and considered a probe an age-DMP for a given cell type if 
the relationship with age was significant at a level of <5 x 10-7.  Consist with our 
observation in the WGBS data, most of the identified age-DMPs were cell type specific, 
with the largest number found in CD4+ cells (Figure 2.7B-E). Only one of the DMPs 
identified as common between all cell types is part of the Horvath methylation-aging 
model. However many of these common age-DMPs, including those near ELOVL2, 
KLF14 and FHL2 have been identified as methylation aging markers in other studies[155, 
156].  Notably, many of the age-DMPs identified as cell type specific have similar 
nearest genes. For example, type specific age-DMPs in the gene body of PRDM16 are 
identified in each cell type, indicating that common genes may be regulated even if the 
highest magnitude of change occurs in different locations for each cell type. 
Discussion 
In this work, we demonstrate cell type specific patterns of methylation change 
with age in two types of peripheral blood cells, CD14+ monocytes and CD4+ T 
lymphocytes. We observe both genome scale change in the form of hypomethylated 
blocks and smaller regions of change, DMR. We demonstrate that the identified small 
DMRs overlap strongly with cell type specific enhancer regions and at least one set of 
DMRs is enriched for a motif at which a cell type regulatory factor binds.  While recent 
work has focused on identifying aging related methylation changes that are common 
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between tissues or identifiable in mixed tissues like peripheral blood, our data 
demonstrates that some methylation change with age is cell type specific and should be 
studied in pure cell types in order to make mechanistic inferences.   
We observe widespread hypomethylation with age accounted for by large 
hypomethylated blocks in CD4+ and naïve CD4+ lymphocytes, but not in monocytes. 
This is highly intriguing as it indicates that methylation in the large, CpG-sparse regions 
affected by blocks is preserved differently in each cell type.  There are many factors 
which could contribute to this difference: CD4+ lymphocytes are part of the adaptive 
immune system, which develops and changes with aging, whilc CD14+ monocytes are 
part of the innate immune system which is less variable with age. CD4+ lymphocytes are 
present within peripheral blood for months to years [157], while CD14+ monocytes 
turnover much more frequently, with a lifespan of days[158], it is possible that loss of 
block methylation could accumulate as CD4+ cells sit in a quiescent state for long 
periods, while CD14+ cells do not stay long enough to accumulate this pattern. 
Additionally, CD14+ cells are not fully differentiated, they become macrophages or 
dendritic cells upon reaching their target tissue. It is possible that there is greater 
protection of global methylation in these cells than in the terminally differentiated CD4+ 
lymphocytes.  
 The pattern of small DMRs observed also strongly suggested differential 
methylation with age may be intimately linked to cell identity.  Using a very stringent 
threshold, we observed a large number of age-DMRs in CD4+, naïve CD4+ and CD14+ 
cells. A small number of these age-DMRs are common between both cell types, 
indicating that there are likely common mechanisms of differential methylation present. 
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The fact that at least some of these regions are nearest to genes with known roles in aging, 
such as MIR30D and PIK3C2A, indicates that the common regions of change may play 
an important role in cellular aging and further work should be done to clarify the 
locations and mechanism underlying such change. However, the majority of regions 
identified were distinct between lymphocytes and monocytes, and the patterns of change 
were also distinct. Lymphocytes have more hypermethylated age-DMRs and monocytes 
have more hypo-methylated age DMRs.  For lymphocytes, methylation aging closely 
resembles the changes observed in cancer sample: widespread hypomethylated blocks 
with local hypermethylation [145]. 
 The strong enrichment for age-DMRs from both cell types in enhancers further 
supports the idea that methylation change with age is closely linked to the cells 
epigenomic identity. Despite the many differences in age-DMRs between monocytes and 
lymphocytes, for both cells types we observed a similar relationship between methylation 
and enhancers: hypomethylated age-DMRs overlap cell type specific enhancers, while 
enhancers from the opposite cell type are enriched in hypermethylated DMRs.  
Methylation patterns in enhancers have been linked to transcription factor binding [159], 
so it is possible that the observed age-DMRs are indicative of altered binding at cell type 
specific regulatory regions with age.  It is striking that the methylation patterns suggest a 
more active binding environment at cell type specific enhancers with age. This could be 
indicative of increased canalization of cell types with age.  
 The observed enrichment of BATF::JUN consensus binding sequence within 
hypomethylated age-DMRs in naïve CD4+ cells illustrates this idea and demonstrates 
how identification of differentially methylated regions can identify important sites of 
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regulation.  Binding at this motif in naïve CD4+ cells facilitates differentiation to Th17 
cells. The balance and function of these cells has been observed to change with aging and 
may play a role in age related inflammatory phenotypes[154, 160]. The observation of 
hypomethylated DMRs in these binding sites provides insight into the stage and 
mechanism by which this pathway may be perturbed in aging. 
Experimental Procedures 
 Human Subjects: 43 healthy donors took part in this study. All participants 
provided written informed consent, and this study was approved by the Johns Hopkins 
Medicine Institutional Review Board (IRB# NA_00052046). Screening criteria for 
donors less than 50 years included diagnosis of diabetes, thyroid disease, high blood 
pressure, depression or anxiety disorder, pregnancy, use of prescription medication other 
than birth control, use of recreational drugs and daily drinking. Screening criteria for 
donors over 50 years included rheumatoid arthritis, gout, COPD, asthma, heart attack 
within 6 months, Parkinson’s disease, hip or knee surgery within 6 months, paralysis by 
stroke, active cancer or cancer diagnosis within 1 year, and use of steroid medications.  
 Cell sorting and DNA extraction: Peripheral blood mononuclear cells were 
isolated using Ficoll  (Sigma-Aldrich). CD4+ T cells and CD14+ Monocytes were 
isolated through positive selection using MACS magnetic bead technology (Miltenyi 
Biotec).  Naïve CD4 T+ Cells were isolated through selection for CD4 and CD45RA. 
Purity, as measured by post-separation flow cytometry was 97% for CD4+ cells, 95% for 
CD14+ cells and 85% for naïve CD4+ cells (Figure 2.1).  Purified cells were flash frozen 
in liquid nitrogen and stored at -80°C. 
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 Whole genome bisulfite sequencing: DNA was extracted from frozen cell pellets 
using the MasterPure DNA Purification kit (Epicentre) according the manufacturer’s 
protocol. 1% unmethylated Lambda DNA (Promega, cat # D1521) was spiked in to 
genomic DNA to monitor the bisulfite conversion efficiency. Genomic DNA was 
fragmented to a target peak of 300-400 bp using the Covaris S2 Focused-ultrasonicator in 
a 50 µl volume according to the manufacturer’s instructions. 
The fragmented DNA was converted to end-repaired, adenylated DNA using the 
NEBNext Ultra End Repair/dA-Tailing Module (New England BioLabs, cat # 7442L). 
Methylated adaptors (NEBNext Multiplex Oligos for Illumina; New England BioLabs, 
cat # E7535L) were ligated to the product from the preceding step using the NEBNext 
Ultra Ligation Module (New England BioLabs, cat # 7445L). The resulting product was 
size-selected as described in the manufacturer’s protocol by employing modified AMPure 
XP bead ratios of 0.4X and 0.2X in order to select for an insert size of 300-400 bp. 
After size-selection the samples were bisulfite converted and purified using the 
EZ DNA Methylation- Gold Kit (Zymo Research, cat # D5005). Bisulfite converted 
libraries were PCR amplified and indexed using primers from the NEBNext Multiplex 
Oligos for Illumina module (New England BioLabs, cat # E7535L) and the Kapa HiFi 
Uracil+ PCR system (Kapa Biosystems, cat # KK2801). PCR enrichment was performed 
with the following cycling parameters: 98°C for 45 sec followed by 10 cycles at 98°C for 
15 sec, 65°C for 30 sec, 72°C for 30 sec and a final extension at 72°C for 1 min. The 
PCR enriched product was cleaned up using 1X AMPure XP beads (Beckman Coulter, 
cat # A63881). 
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The resulting libraries were sequenced at a 2x100 bp read length on the Illumina 
HiSeq2000 platform using v3 chemistry according to the manufacturer’s protocol.  
 Sequencing data analysis: All analyses were performed using R 3.0.1. To process 
sequencing data, we ran the BSmooth [45] bisulfite alignment pipeline on the 100-by-100 
bp HiSeq 2000 paired end sequencing reads obtained for each sample, using Bowtie2 
version 2.2.2 [142] and the hg19 build on the human genome as well as the genome for 
lambda phage. Table 2.2 summarizes the alignment results. After alignment, BSmooth 
was used to extract read-level measurements, summarized in Table 2.2. We filtered out 
measurements with mapping quality <20 or nucleotide base quality <10 and we removed 
measurements from the 5’ most 10 nucleotides of both mates. BSmooth was used to sort 
read-level measurements by genomic coordinates and compile a summary table.  
BSmooth was used to identify large hypomethylated blocks and small DMRs as 
described in detail previously [28, 31].  CpGs with coverage of 2 or greater in each cell 
type/age group were included in the analysis. We used the same cutoffs used in studies of 
cancer, specifically a t-statistic cutoff of ±2 for block finding and a t-statistic cutoff of 
±4.6 for small DMR finding. 
 Chromatin peak information for naïve CD4 cells and monocytes was obtained 
from the Roadmap project [150], downloaded from egg2.wustl.edu/roadmap/wed_portal. 
Narrow peaks were used. Overlap with DMRs was calculated based on the odds ratio for 
each analyzed CpG occurring in each type of region. 
 Motif Finding: Identification of enriched motifs within DMR lists was performed 
using Haystack, as described in detail elsewhere [151]. Enrichment within hypo and 
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hyper methylated DMR lists for each cell type was compared to a background of all other 
DMRs. 
 Cytokine quantification: IL-6 was quantified in stored serum using Human IL-6 
Quantikine ELISA kit (R&D systems) according to manufacturer’s instructions. IL-17 
was quantified in stored serum using Human IL-17A High Sensitivity ELISA kit 
(eBiosciences, San Diego, CA). 
 450k Array: DNA was quantified using Quant-iT Picogreen Reagent (Invitrogen) 
according to manufacturer’s instructions. 500 ng of DNA was bisulfite converted using 
the EZ DNA methylation kit (Zymo Research) according to the manufacturer’s 
specifications for the 450k array. Converted genomic DNA was eluted in 11 µl of elution 
buffer. DNA methylation level was measured using Illumina Infinium HD Methylation 
Assay (Illumina) according to the manufacturer’s instructions. 
 450k Analysis: All analyses were performed using R 3.0.3. Raw intensity files 
were obtained and processed using the Minfi package [161] to obtain methylation ratios 
(Beta values). Samples were normalized using the Illumina preprocessing method 
implemented in Minfi. We applied multiple quality control measures to remove 
questionable arrays or probes. We examined 450k array control probes to assess many 
measures of assay efficiency and calculated median methylated and unmethylated 
measurements for each sample. We removed probes that had an annotated SNP 
(dbSNP137) at the single base extension or CpG site (17541 probes removed). 
Methylation age was calculated using 353 probe seen to be predictive of chronological 
age as detailed elsewhere [89].  Age associated differentially methylated probes were 
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identified using a linear model including race (white, black, other) and sex and adjusted 




Figure 2.1: Validation of magnetic bead purification.  
Cell populations purified using magnetic beads were analyzed using flow cytometry to determine 




Figure 2.2: Widespread hypomethylated blocks in aged CD4+ cells. 
A) Global hypomethylation with age in CD4+ lymphocytes. Distribution of high-frequency 
smoothed methylation values for CD4+ lymphocytes from CpGs with sufficient coverage from 
WGBS. Younger samples are shown in orange, older samples are shown in green.  B) No global 
changes with age in CD14+ monocytes. Distribution of high-frequency smoothed methylation 
values for CD14+ monocytes from CpGs with sufficient coverage from WGBS. Younger samples 
are shown in orange, older samples are shown in green. C) Example of hypomethylated block 
identified by WGBS. Shown are smoothed methylation values within blocks identified comparing 
younger (orange) and older (green) CD4+ samples. D) Naïve CD4+ cells are hypomethylated 
with age in CD4+ age-blocks. Shown is the distribution of mean methylation within regions 
identified as age-blocks in CD4+ cells for CD4+ and naïve CD4+ samples from older and 
younger individuals. 
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Figure 2.3: Cell type specific age-DMRs. 
A) Example of hypermethylated CD4+ age-DMR identified by WGBS. Top panel: lines show 
smoothed methylation values within DMR identified comparing younger (blue) and older (red) 
CD4+ samples, points show raw methylation values. Middle Panel: CpG density across the 
identified region. Bottom panel: the location of genes within the identified region. Solid regions 
indicate exon locations. B) Example of hypermethylated naïve CD4+ age-DMR identified by 
WGBS. Top panel: lines show smoothed methylation values within DMR identified comparing 
younger (purple) and older (green) naive CD4+ samples, points show raw methylation values. 
Middle Panel: CpG density across the identified region. Bottom panel: the location of genes 
within the identified region. Solid regions indicate exon locations.  C) Example of 
hypomethylated CD14+ age-DMR identified by WGBS. D) Example of common age DMR 
identified comparing older and younger samples in all three cell types. E) Hypomethylated age-
DMRs are primarily cell type specific. Shown is a Venn diagram representing the number of 
regions identified as hypomethylated age-DMRs within each cell type. F) Hypermethylated age-
DMRs are primarily cell type specific. Shown is a Venn diagram representing the number of 
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Figure 2.4: Age-DMRS are enriched for cell type specific enhancers and regulatory factor 
binding sites. 
A) Naïve CD4+ age-DMRs are enriched for naïve CD4+ and CD14+ enhancer regions. Shown 
are odds-ratios for the overlap between hyper and hypomethylated naive CD4+ age DMRs and 
ChIP-seq peaks for each cell type.  B) CD14+ age-DMRs are enriched for naïve CD4+ and 
CD14+ enhancer regions. Shown are odds-ratios for the overlap between hyper and 
hypomethylated naive CD4+ age DMRs and ChIP-seq peaks for each cell type. C) The 
BATF::JUN binding motif found to be enriched in naïve CD4+ age-DMRs. D) Center enrichment 
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Figure 2.5: Cytokine levels in donor serum.  
A) Log transformed IL-6 (pg/mL) measured by ELISA in stored serum from donors. B) Log 
transformed IL-17 (pg/mL) measured by ELISA in stored serum from donors. 
  
 
Figure 2.6: Validation of WGBS blocks and DMRs in 450k array data. 
A) Shown is the distribution of mean CD4+ cell methylation from 450k array probes outside of 
regions identified as CD4+ age-blocks using WGBS (solid lines) or inside regions identified as 
CD4+ age-blocks using WGBS (dotted lines).  Means all CD4+ samples from donors under 35 
years shown in red, means from all CD4+ samples from donors over 80 years shown in black. B) 
Shown is the mean differential methylation measured using WGBS versus the mean differential 
methylation between samples from donors under 35 years and samples from donors over 80 years 
for regions identified as age-DMRs using WGBS which are covered by 3 or more probes in the 
450k array. CD14+ age-DMRs are shown in black, CD4+ age-DMRs are shown in red, naïve 











































































































































































































Figure 2.7: Cell type specific age-related methylation changes in 450k data. 
A) Methylation age correlates with chronological age in all cell types. Shown is the “methylation 
age” calculated from 450k data using Horvath’s algorithm versus the chronological age for each 
sample. CD14+ monocytes are shown in black, CD4+ lymphocytes are shown in blue, peripheral 
blood mononuclear cells are shown in pink.  B) Age-DMPs are primarily cell type specific. 
Shown is a Venn diagram depicting the overlap of the most significant age-DMPs identified in 
each cell population. C) Example common age-DMP. Shown is methylation versus chronological 
age for a probe identified as a significant DMP for all cell types. D) Example CD14+ only age-
DMP. Shown is methylation versus chronological age for a probe identified as a significant DMP 
for CD14+ cells only. E) Example CD4+ only age-DMP. Shown is methylation versus 


































































































































































































































































































































































































 Table 2.1: Donor Characteristics 
ID Age Sex Race WGBS? 
Y138 18 F W yes 
Y140 20 M B no 
Y171 23 F O no 
Y134 25 F B no 
Y147A 25 F W yes 
Y172 25 F W yes 
Y135 26 F B no 
Y136 26 M W no 
Y139 30 F B no 
Y154 30 M W no 
Y141 31 F B no 
Y137 33 M B no 
Y145 33 M B no 
Y163 38 F W no 
Y143 39 M B no 
Y146 42 F B no 
Y159 44 F W no 
Y150 46 M B no 
Y164 47 M B no 
Y158 49 M W no 
Y165 50 M B no 
F943 70 F W no 
F929 70 M W no 
F955 71 F W no 
F957 73 F W no 
F971 73 M W no 
F945 74 F W no 
F965 74 M W no 
F950 75 F W no 
F948 75 F W no 
F827A 77 M O no 
F891 80 M W no 
F879A 82 F W yes 
F951 82 F W yes 
F954 82 M W no 
F920 84 F W no 
F963 84 M W no 
F927 85 F B no 
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ID Age Sex Race WGBS? 
F600A 86 F W yes 
F598A 87 F W no 
F940 88 M W no 
F944 89 M W no 




Table 2.2:WGBS Summary 
Sample alignment 
rate 






600A_14 0.833769908 28220561 25030852 0.89 5.46 0.9970 
600A_4 0.834642824 28220561 24993780 0.89 5.11 0.9970 
600A_n4 0.832945317 28220561 25131636 0.89 5.68 0.9972 
819-14 0.835926723 28220561 25168034 0.89 5.75 0.9970 
819-4 0.832601224 28220561 25260938 0.90 5.84 0.9969 
819-n4 0.835227016 28220561 25223628 0.89 5.89 0.9971 
951_4 0.835235647 28220561 25109823 0.89 5.98 0.9974 
951_n4 0.835179283 28220561 25114414 0.89 5.97 0.9972 
951-14 0.834172999 28220561 25192030 0.89 5.78 0.9971 
Y138-14 0.838714195 28220561 25100392 0.89 5.75 0.9973 
Y138-4 0.833807559 28220561 25176395 0.89 6.05 0.9973 
Y138-n4 0.834665359 28220561 25113086 0.89 5.70 0.9973 
Y147-14 0.83449785 28220561 25134611 0.89 5.69 0.9973 
Y147-4 0.834247565 28220561 25125406 0.89 5.83 0.9973 
Y147-n4 0.833491385 28220561 25150996 0.89 5.90 0.9974 
Y172-14 0.835691499 28220561 25149409 0.89 5.83 0.9974 
Y172-4 0.833406479 28220561 25210524 0.89 5.80 0.9973 
Y172-n4 0.832528324 28220561 25234685 0.89 5.89 0.9970 
 
Table 2.3: DMR finding summary 












CD4 475 1012 -35% (-18%,-
60%) 
40% (16%,69%) 
CD14 762 172 -37% (-20%,-
61%) 
37% (22%,61%) 
nCD4 1495 2150 -30%(-3%,-77%) 35% (22%,63%) 
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Table 2.4: Common age-DMRs 







chr1 105500662 105500779 AMY1B 1208200 hypermethylated 
chr10 28231642 28231940 ARMC4 56036 hypermethylated 
chr11 17195624 17195872 PIK3C2A 4271 hypermethylated 
chr12 39363664 39364307 CPNE8 64245 hypermethylated 
chr18 74310656 74310991 LOC284276 70045 hypermethylated 
chr20 43312316 43312651 WISP2 31233 hypermethylated 
chr6 122708685 122709030 HSF2 11665 hypermethylated 
chr8 135826473 135826599 MIR30D 9286 hypermethylated 
chr8 137048462 137048644 KHDRBS3 578747 hypermethylated 
chr9 31211270 31211481 ACO1 1173119 hypermethylated 
chr12 38284939 38285270 ALG10B 425286 hypomethylated 
chr16 10794038 10794738 TEKT5 5237 hypomethylated 
chr2 4981405 4981765 SOX11 851033 hypomethylated 
chr2 101247565 101248116 PDCL3 68148 hypomethylated 









Chapter 3: DNA methylation is stable during replication and 




DNA methylation is an epigenetic modification that has important functions in 
mammalian development. It consists of addition of a 5’ methyl group to the cytosine base.  
This modification is most frequently found in the context of CpG dinucleotides, where it 
can be placed by three methyltransferase enzymes: DNMT1, the maintenance 
methyltransferase that re-establishes the methylation pattern following DNA replication, 
and DNMT3a and DNMT3b, which function in de novo methylation [6].  The presence of 
DNA methylation in gene promoters and enhancers decreases gene expression, likely 
through alterations of local DNA structure and prevention of transcription factor binding 
[143]. Changes in methylation are associated with aging, oncogenesis and other diseases 
[25, 89, 162-164].  
Several molecular processes, including gene expression and chromatin structure, 
are known to change through the cell cycle [165-167]. These changes will result in 
unwanted variation between measures on bulk, unsynchronized cells. Computational 
approaches have been suggested to control for this variation [168, 169]. 
The extent to which DNA methylation changes throughout the cell cycle is 
currently unknown. Previous studies of methylation during the cell cycle have focused on 
the maintenance of methylation during DNA replication. The maintenance 
methyltransferase, DNMT1, localizes to newly synthesized DNA and is associated with 
the replication complex during S-phase and with other transcription factors during G0/G1 
and G2/M phases [170]. A previous study in HeLa cells reported increased methylation 
during S phase using immunofluorescence and HPLC [171].  By contrast, a more recent 
study using flow cytometry to quantify 5-methylcytosine in two cancer cell lines found 
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no differences in the ratio of 5-methylcytosine staining to DNA content between G1 and 
S phase, but noted a lag in early G2/M before the maximum levels of 5mC were observed 
[172]. While these studies provide valuable insight into the methylation of newly 
synthesized DNA, both studies focus on changes during DNA synthesis, and neither 
provides region specific data.  
We have previously reported the presence of large hypomethylated domains, 
encompassing up to two thirds of the genome, termed “hypomethylated blocks”, in colon 
cancer samples and associated with EBV transformation of lymphocytes. These blocks 
occur in gene-poor regions and overlap strongly with heterochromatic and lamina-
associated domains, indicating large-scale epigenetic structural changes [28, 31, 145]. 
These hypomethylated blocks also overlap strongly with regions of intermediate 
methylation in IMR90 cells [27]. A single cell can be methylated (100% methylation), 
hemimethylated (50% methylation), methylated in an allele specific manner (50% 
methylation) or unmethylated (0% methylation) at a given location, so the consistent 
observation of regions with intermediate methylation levels suggests that methylation in 
these areas are highly variable within cell populations. Intriguingly, large regions of 
hypomethylation are also observed in cells approaching replicative senescence [95]. In 
this context, hypomethylation was found in regions that replicate late in S phase, 
concurrent with decreased expression and decreased localization of DNMT1 to these 
domains in late passage cells late passage cells. 
We noted that in both the cancer and EBV studies, hypomethylated blocks are 
seen in conditions where there is also an increase in the proportion of cells that are 
actively proliferating. Colon cancer is associated with increased cell proliferation outside 
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of the normal proliferative zone of colonic crypts as measured by Ki67 staining [173, 
174] . EBV transformation directly promotes proliferation of previously resting cells by 
inducing expression of early G1 regulators [175].  Normal tissues are often distinguished 
by differences in the percent of proliferating cells, so any differences in methylation 
attributed to proliferation may be relevant to studies of tissue specific methylation as well 
[176].  Given these observations, we asked whether the observed hypomethylated blocks 
might be attributed to changes in the proportion of actively dividing cells within the 
populations studied. [170-172] 
In this study, we sought to more fully elucidate the genome-scale changes in DNA 
methylation associated with cell proliferation. We used early passage primary dermal 
fibroblasts to avoid any artifacts from long-term cell culture and isolated quiescent and 
proliferating cells using flow cytometry. We further subdivided the proliferating cells into 
G1 and G2 phases to identify methylation changes as a result of DNA replication. We 
observed strikingly high degree of correlation between methylation across cell cycle 
phases within and between primary fibroblasts. We found no hypomethylated blocks or 
global changes in methylation associated with proliferation. 
Results 
No global changes in methylation associated with cell proliferation or replication 
We sought to identify potential genome scale changes in DNA methylation 
associated with cell proliferation.  Working with 3 sets of early passage (P4) primary 
human dermal fibroblasts (details in Table 3.1), we used fluorescence activated cell 
sorting to separate cells into three groups based on staining with anti-Ki67 and Propidium 
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Iodide: Quiescent (G0) cells were sorted based on negative Ki67 staining and 2N DNA 
and represented 46-71% of live cells; G1 cells were identified as Ki67 positive and 2N 
DNA and represented 5-21% of live cells; G2/M cells were identified as Ki67 positive 
and 4N DNA and represented 3-5% of live cells (Figure 3.1C).  In addition, each set of 
primary cells was arrested by contact inhibition for 1 week to examine the influence of 
extended quiescence.  After one week, 0.05-0.6% of all cells were in G2/M. Ki67 
negative, 2N DNA cells were again isolated (Figure 3.1D).  
In order to gain unbiased genome wide information about DNA methylation in 
these samples, we performed whole genome bisulfite sequencing (WGBS).  We 
generated sequencing data to a depth of 5.3-8.6X and analyzed it using the BSmooth 
algorithm, which was designed for analyzing low-coverage WGBS data and has been 
demonstrated to accurately estimate methylation levels at single-base pair resolution by 
borrowing information from nearby CpGs [45]. After filtering reads with low quality 
measures, we obtained measurements for an average of 25,425,530 CpGs per sample 
(average of 90% coverage).  Bisulfite conversion was assessed using spiked in lambda 
phage and ranged from 99.67-99.71% (Details in Methods, Table 3.2). 
  To identify potential large-scale changes in methylation associated with cell cycle 
stage, we analyzed data from all CpGs with two or more reads for at least two out of 
three of the samples for each cell cycle phase. The genome wide distribution of 
methylation was strikingly similar between samples within a cell cycle phase and 
between phases, with mean methylation ranging from 60-65% (shown in Figure 3.2A-C, 
summarized in Table 3.3). When we separately examined CpGs within the regions 
identified as hypomethylated blocks in colon cancer samples, we observed lower 
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methylation across all samples within colon cancer blocks as compared to outside, 
however no large differences were found between the cell cycle phases within or outside 
the blocks (Figure 3.2D).   
When we compared mean methylation for each phase across all CpGs, we found a 
very strong correlation between methylation across all comparisons (Figure 3.3), 
indicating that large-scale differences observed in other settings are not found between 
cell cycle phases. Consistent with this observation, when we used BSmooth to identify 
potential methylation blocks within our dataset, none were identified using the criteria 
applied in previous work. 
Discussion 
In summary, we use low coverage whole genome bisulfite sequencing to 
demonstrate consistent levels of DNA methylation across phases of the cell cycle in 
human primary fibroblasts.  We used flow sorting to isolate resting and actively dividing 
cells from low passage primary cell culture and also examined the same cells after one 
week of arrest.  We observed a very strong correlation between methylation in each 
examined cell cycle phase within each donor’s cells and between donors, with no 
evidence of genome wide change associated with either replication or quiescence. 
This finding is informative for interpreting large-scale changes in methylation 
identified in other settings, including colon cancer, EBV immortalization and cellular 
senescence.  We previously observed widespread hypomethylated blocks associated with 
colon cancer and EBV transformation [28, 31, 145]. Intriguingly, these hypomethylated 
blocks generally involve highly methylated regions shifting to intermediate levels of 
methylation, indicating that these regions are more variably methylated within the cell 
 110 
population examined. Both of these conditions are associated with increased cell 
proliferation, and thus an increased percentage of Ki67+ and G2 cells within the 
population studied, which we hypothesized could explain such heterogeneity.  However, 
our results indicate that these changes alone would not lead to the observed widespread 
hypomethylation.  Further, while the results of a recent work by Cruikshanks et al. 
implicate proliferative history in the development of hypomethylated blocks [95], our 
results indicate that proliferation, as measured by Ki67 positivity or 4N DNA content, in 
low passage fibroblasts is not sufficient for this change. It is possible that our findings 
would be different in late passage cells, as Cruikshanks et al. indicate defects in DNMT1 
localization only in late passage cells.  
We examined cells that were arrested by contact inhibition for one week in order 
to determine if methylation changes would be introduced or accentuated by an extended 
exit from the cell cycle, similar to many somatic cell types in vivo.  We did not observe 
any large-scale change in methylation associated with the extended cell cycle arrest. 
However, this length of contact inhibition is much shorter than the length of time many 
somatic cells spend without dividing, so it remains possible that global methylation 
changes observed in vivo may be linked to extended exit from the cell cycle.  
Two previous studies examining global methylation levels across the cell cycle 
have focused on the dynamics of methylation maintenance during S phase, with an early 
work reporting hypermethylation during DNA replication and a contradictory recent 
work showing a linear relationship between DNA content and 5mC signal during 
replication [171, 172]. We did not examine S phase, as using partially replicated DNA 
would be particularly challenging to accurately measure methylation levels using low 
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coverage sequencing data. While Desjobert et al. report a lag in the time at which they 
detect maximum DNA content and maximum methylation signal in G2/M [172], our data 
shows no significant hypomethylation in G2/M cells, indicating that if such a lag exists, 
the duration and magnitude are not sufficient to be detected by our WGBS analysis. 
Interpretation of our data is also limited by the use of a single cell type. We chose 
to use low passage primary fibroblasts to make our data relevant to the study of primary 
tissue samples.  However these cells are less proliferative than ES or cancer cell lines and 
our data indicate that they have significant levels of intermediate methylation. It is 
possible that proliferation or cell cycle dependent changes may be present in other cell 
types.  
Experimental Procedures 
Tissue Culture: Primary dermal fibroblasts were maintained in Dulbecco’s 
Modified Eagle Medium DMEM (Life Technologies) supplemented with 15% FBS 
(Gemini BioProducts) and 1X Pen/Strep (Gibco).  Cells were incubated at 37°C with 5% 
CO2.  Donor information for each cell line is listed in Table S1. 
Fluorescence-activated Cell Sorting: Passage 4 cells were detached using 
trypsin (Life Technologies). Trypsin was neutralized using trypsin neutralization buffer 
(ATCC), washed, fixed in cold 75% ethanol and stored at -20°C.  Fixed cells were 
washed in PBS containing 1% FBS, 0.09% NaN3.  Cells were stained with FITC 
conjugated Mouse Anti-Human Ki67 (clone B56) and 25 ug/mL propidium iodide 
solution (Sigma).  Fluorescence activated cell sorting analysis was performed using a 
Beckman Coulter MoFlo Cell Sorter. 
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Whole Genome Bisulfite Sequencing:1% unmethylated Lambda DNA 
(Promega, cat # D1521) was spiked in to genomic DNA to monitor the bisulfite 
conversion efficiency. 50-100 ng of genomic DNA was fragmented to a target peak of 
300-400 bp using the Covaris S2 Focused-ultrasonicator in a 50 µl volume according to 
the manufacturer’s instructions. 
The fragmented DNA was converted to end-repaired, adenylated DNA using the 
NEBNext Ultra End Repair/dA-Tailing Module (New England BioLabs, cat # 7442L). 
Methylated adaptors (NEBNext Multiplex Oligos for Illumina; New England BioLabs, 
cat # E7535L) were ligated to the product from the preceding step using the NEBNext 
Ultra Ligation Module (New England BioLabs, cat # 7445L). The resulting product was 
size-selected as described in the manufacturer’s protocol by employing modified AMPure 
XP bead ratios of 0.4X and 0.2X in order to select for an insert size of 300-400 bp. 
 
After size-selection the samples were bisulfite converted and purified using the 
EZ DNA Methylation- Gold Kit (Zymo Research, cat # D5005). Bisulfite converted 
libraries were PCR amplified and indexed using primers from the NEBNext Multiplex 
Oligos for Illumina module (New England BioLabs, cat # E7535L) and the Kapa HiFi 
Uracil+ PCR system (Kapa Biosystems, cat # KK2801). PCR enrichment was performed 
with the following cycling parameters: 98°C for 45 sec followed by 10 cycles at 98°C for 
15 sec, 65°C for 30 sec, 72°C for 30 sec and a final extension at 72°C for 1 min. The 
PCR enriched product was cleaned up using 1X AMPure XP beads (Beckman Coulter, 
cat # A63881). 
 113 
The resulting libraries were sequenced at a 2x100 bp read length on the Illumina 
HiSeq2000 platform using v3 chemistry according to the manufacturer’s protocol.  
Data Analysis: All analyses were performed using R 3.0.1. To process 
sequencing data, we ran the BSmooth [24] bisulfite alignment pipeline on the 100-by-100 
bp HiSeq 2000 paired end sequencing reads obtained for each sample, using Bowtie2 
version 2.1.0 [43] and the hg19 build on the human genome as well as the genome for 
lambda phage. Supplementary Table S2 summarizes the alignment results. After 
alignment, BSmooth was used to extract read-level measurements, summarized in 
Supplementary Table S2. We filtered out measurements with mapping quality <20 or 
nucleotide base quality <10 and we removed measurements from the 5’ most 10 
nucleotides of both mates. BSmooth was used to sort read-level measurements by 
genomic coordinates and compile a summary table.  
Next, BSmooth was used to identify large hypomethylated blocks as described in 
detail previously [17, 24, 25]. CpGs with coverage of 2 or greater in each sample group 
were included in the analysis. We used the same cutoffs used in studies of cancer, 




Figure 3.1: Sorting of fibroblasts based on Ki-67 expression and DNA content. 
A) Live cells were selected using forward scatter and side scatter. B) Single cells were selected 
using pulse width. C) Cells from actively proliferating culture were sorted into “G0”: 2N DNA 
and Ki67 negative, “G1”: 2N DNA and Ki67 positive, “G2/M”: 4N DNA and Ki67 positive. D) 
Cells from culture arrested by contact inhibition for one week were predominantly “G0”. 
 
Figure 3.2: Global methylation is consistent after replication and cell cycle arrest.  
(A-C) Distribution of high-frequency smoothed methylation values from CpGs with sufficient 
coverage from whole genome bisulfite sequencing (WGBS) for each donor profiled. (D) 
Distribution of mean high-frequency smoothed methylation values from CpGs within and outside 
the regions previously identified as hypomethylated blocks in colon cancer for each phase 
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Figure 3.3: Global methylation is highly correlated between cell cycle phases.  
(A-D) Shown is hexagonal binning of mean methylation per CpG for all samples in G0 versus all 
samples in extended G0 (A), all samples in G1 versus all samples in G0 (B), all samples in G2 
versus all samples in G1 (C), all samples in extended G0 versus all samples in G2 (D). 
Table 3.1: Primary cells analyzed 





FA Gibco C-013-5C 1474560 36 Female Caucasian 
FB Lonza CC-2511 352805 40 Female Caucasian 
FC ATCC PCS-201-012 61447289 34 Female Caucasian 
 
  
































































































































































Table 3.2: WGBS Summary 




depth (X) conversion 
FA_Ext_G0 0.8166 25514228 0.9041 7.2102 0.9970 
FA_G0 0.8171 25647479 0.9088 8.6014 0.9970 
FA_G1 0.8242 24826013 0.8797 5.2842 0.9971 
FA_G2 0.8137 25322198 0.8973 6.6033 0.9971 
FB_Ext_G0 0.8131 25350618 0.8983 6.2853 0.9971 
FB_G0 0.8086 25393776 0.8998 6.9167 0.9970 
FB_G1 0.8176 25312601 0.8970 5.6864 0.9968 
FB_G2 0.8034 25313403 0.8970 5.6074 0.9971 
FC_Ext_G0 0.8120 25647389 0.9088 7.5433 0.9970 
FC_G0 0.8148 25665135 0.9094 7.4768 0.9970 
FC_G1 0.8169 25602198 0.9072 7.1322 0.9969 
FC_G2 0.8018 25511322 0.9040 6.5058 0.9968 
 
Table 3.3: Mean Methylation 
Methylation 
Mean (1st, 3rd 
Quartile) 
FA FB FC 

































Cellular senescence is a protective response in which a cell permanently exits the 
cell cycle in response to cell stress. It was first characterized in vitro by Hayflick who 
noted that primary fibroblasts have a limited replicative lifespan before exiting the cell 
cycle [177]. The response can also be induced in culture through serial passage, 
expression of oncogenes, or induction of genotoxic stress (reviewed elsewhere [53]). 
The induction of senescence in vitro is characterized by specific cellular changes. 
The senescence response in serially passaged cells is partially attributed to shortening of 
telomere sequences, which induces a DNA damage response [178]. In addition to 
telomere shortening, senescent cells are characterized by a change in pH allowing for 
positive beta galactosidase staining [54], and epigenomic changes including a 
redistribution heterochromatin marks and loss of nuclear lamina proteins [179, 180].   
Recent work by multiple groups indicates that DNA methylation is altered with 
extended culture of primary cells. Bork et al. have identified specific CpGs differentially 
methylated with replicative and stress induced senescence in mesenchymal stromal cells 
[181].  Horvath reports an increase in “methylation age” with serial passage of cultured 
fibroblasts [89]. Work by Cruikshanks et al. identified widespread hypomethylated 
blocks, similar to those observed in colon cancer, associated with replicative senescence 
in IMR-90 cells [95].  We cultured primary neonatal dermal fibroblasts to the point of 
growth arrest to further examine methylation changes associated with extended culture 
and replicative senescence and to determine the relevance of this system as a in vitro 
model of methylation aging.  
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Serial passage of primary fibroblasts 
In order to investigate the effects of serial passage on primary cells, primary 
neonatal dermal fibroblasts (Lonza) were cultured in DMEM (Gibco) with 15% FBS 
(Gemini BioProducts) until there was no population doubling after 2 weeks, which 
occurred at passage 33.  To verify that the growth arrest was consistent with replicative 
senescence, telomere length from early passage (passage 7) and senescent (passage 33) 
cells was measured by qPCR, comparing the amount of telomere repeat sequence 
compared to a single copy locus, 36B4, as detailed by Cawthorn et al. [182]. A 
significant decrease in the telomeric: single copy ratio was observed in passage 33 cells 
(average ratio 0.48) compared to passage 7 cells (average ratio 1.38). 
450k analysis of methylation 
Genomic DNA was extracted from passage 7 and passage 33 cells.  Three 
technical replicates of DNA from each passage was bisulfite converted and genome wide 
methylation was analyzed using the 450k array. Array data was processed using Minfi 
and normalized using the preprocess Illumina method [110]. Consistent with Cruikshanks 
et al.’s observations, application of Minfi’s blockfinder identified large hypomethylated 
blocks in passage 37 cells, encompassing up to 235 Mbp (examples in Figure A.1A – 
A.1B). 
WGBS analysis of methylation 
To better characterize the pattern and timing at which widespread hypomethylated 
blocks develop during serial passage, genomic DNA from cells at the earliest available 
stage of culture (passage 4), cells at passage 7, cells at an intermediate stage of culture 
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(passage 10), cells approaching replicative senescence (passage 31) and cells at the final 
passage (passage 33) was analyzed using WGBS.  We generated sequencing data to a 
depth of 8.0-8.9X and analyzed it using the BSmooth algorithm [45]. After filtering reads 
with low quality measures, we obtained measurements for an average of 25,749,493 
CpGs per sample (average of 91% coverage) (summarized in Table A.1).  Considering 
CpGs with >2 coverage in all samples, global methylation was observed to decrease 
progressively with each stage of passage (Table A.1). Consistent with our observations 
from 450k and the work of Cruikshanks et al., the majority of hypomethylation was 
observed within regions identified as hypomethylated blocks in colon cancer (Figure 
A.1C-A.1D). Notably, global and block methylation is similar between passage 31 (when 
culture was still actively proliferating) and passage 33 (when the culture failed to double), 
suggesting the observed change may not be specific to cell cycle arrest. 
Summary 
We observe widespread genomic blocks of hypomethylation in primary 
fibroblasts cultured to replicative senescence, consistent with previously reported 
methylation changes with senescence. The similarity between the changes observed in 
this system and those observed in cancer and aging suggest a possible link between a 
cell’s replicative history and the development of large-scale epigenetic change. This 
finding provides a useful system for examining both the mechanism through which 
widespread methylation changes occur and the functional consequences of these changes 




Figure A.1: Hypomethylated blocks in serially passaged fibroblasts. 
A-B) Example of a regions identified as a block comparing passage 7 (black) and passage 37 
(red) fibroblasts using 450k data. Shown are methylation beta values (methylated signal/total 
signal) for “collapsed” measurements of methylation from open sea probes in 450k data. These 
are methylation averages for each 1500 bp open sea region calculated as part of the Minfi’s 
“block finder” algorithm. The points represent individual samples at each location, solid lines 
represent the smoothed average for each group. C) Distribution of high-frequency smoothed 
methylation values from CpGs within regions previously identified as hypomethylated blocks in 
colon cancer [28] with sufficient coverage from whole genome bisulfite sequencing (WGBS) for 
each sample analyzed. Methylation from passage 4 cells is depicted in pink, from passage 7 cells 
in light green, from passage 10 cells in dark green, form passage 31 cells in orange, from passage 
33 cells in purple. D) Distribution of high-frequency smoothed methylation values from CpGs 
outside of regions previously identified as hypomethylated blocks in colon cancer [28] with 
sufficient coverage from whole genome bisulfite sequencing (WGBS) for each sample analyzed. 
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Table A.1: WGBS Summary 







Passage 4 0.8226 28220561 25826157 0.9152 8.9000 67.9% 
Passage 7 0.8260 28220561 25786408 0.9137 8.4778 66.2% 
Passage 10 0.8250 28220561 25720034 0.9114 7.9993 65.8% 
Passage 31 0.8227 28220561 25766420 0.9130 8.4733 60.3% 
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